Calcium dependent protein kinase 1 in Cryptosporidium parvum (CpCDPK1): attempts to produce knockout parasites and functional studies by Zheng, Wanpeng
  
From the  
Institute of Parasitology  
Faculty of Veterinary Medicine 
Leipzig University 
Calcium dependent protein kinase 1 in Cryptosporidium 
parvum (CpCDPK1): attempts to produce knockout 
parasites and functional studies 
 
 
Inaugural-Dissertation 
to obtain the degree of a 
Doctor medicinae veterinariae (Dr. med. vet.) 
from the Faculty of Veterinary Medicine 
Leipzig University 
 
 
 
 
 
Submitted by 
Wanpeng Zheng 
From Chengdu, China 
 
 
 
Leipzig, 2020
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
With the permission of the Faculty of Veterinary Medicine, Leipzig University 
 
Dean: Prof. Dr. Dr. Thomas Vahlenkamp 
Supervisor: Prof. Dr. Arwid Daugschies 
Reviewers: Prof. Dr. Arwid Daugschies  
Institute of Parasitology 
Faculty of Veterinary Medicine 
Leipzig University 
 
Prof. Dr. Christina Strube 
Institute of Parasitology 
University of Veterinary Medicine Hannover, Foundation 
 
Date of defense:  04.02.2020
  
 
 
 
 
 
 
 
 
 
 
Dedicated to my most staunch supporters – for my wife and my parents
  
 
 
  
Contents 
i 
 
Contents 
1. Introduction ............................................................................................................. 1 
2. Literature Review.................................................................................................... 2 
2.1 Biology ...................................................................................................... 2 
2.1.1 Systematics ........................................................................................ 2 
2.1.2 Life cycle ........................................................................................... 2 
2.1.3 Tenacity of oocysts ............................................................................ 4 
2.1.4 Excystation of oocysts and invasion of host cells .............................. 4 
2.1.5 Formation of the PV........................................................................... 6 
2.1.6 Nutrient supply by the host ................................................................ 7 
2.2 Epidemiology ............................................................................................ 8 
2.2.1 Human Cryptosporidiosis .................................................................. 8 
2.2.2 Animal Cryptosporidiosis .................................................................. 9 
2.3 Detection and Diagnosis ......................................................................... 11 
2.4 Treatment options ................................................................................... 12 
2.5 Hygiene ................................................................................................... 14 
2.6 Vaccine ................................................................................................... 16 
2.7 In vitro and vivo Models ......................................................................... 16 
2.8 Structure and function of Calcium-dependent protein kinases ............... 18 
3. Animals, materials and methods ........................................................................... 21 
3.1 Animals and materials............................................................................. 21 
3.1.3 Mice ................................................................................................. 21 
3.1.4 Cells ................................................................................................. 21 
3.1.5 C. parvum oocysts ............................................................................ 21 
3.1.6 Reagents ........................................................................................... 21 
3.1.7 Plasmids and oligonucleotides ......................................................... 23 
3.1.7.1 Plasmids ............................................................................. 23 
3.1.7.2 Primers and probes ............................................................. 24 
3.1.8 Kits ................................................................................................... 25 
3.1.9 Instruments and software ................................................................. 25 
3.2 Methods................................................................................................... 26 
3.2.1 Preparation of reagents .................................................................... 26 
3.2.2 C. parvum oocysts maintaince ......................................................... 27 
3.2.3 PCR .................................................................................................. 27 
3.2.3.1 Amplification of NdeI and AatII flanked 5’CDPK1.......... 27 
3.2.3.2 Annealing of gRNA ........................................................... 27 
3.2.3.3 Amplification of repair cassette via Touchdown PCR 
(TD-PCR) 28 
3.2.3.4 Colony PCR ....................................................................... 29 
3.2.3.5 Real-time PCR for C. parvum hsp70 ................................. 30 
3.2.4 Restriction enzyme digestion ........................................................... 31 
Contents 
ii 
 
3.2.4.1 Restriction enzyme digestion of pA - pD .......................... 31 
3.2.4.2 Enzyme digestion and dephosphorylation of p185 ............ 31 
3.2.5 Agarose gel electrophoresis ............................................................. 32 
3.2.6 Gel purification ................................................................................ 32 
3.2.7 Ligation ............................................................................................ 33 
3.2.7.1 Ligation of CDPK1 KO plasmids ...................................... 33 
3.2.7.2 Ligation of gRNA and p185 .............................................. 33 
3.2.8 Transformation ................................................................................. 34 
3.2.9 Plasmid extraction ............................................................................ 34 
3.2.10 C. parvum oocysts excystation ........................................................ 35 
3.2.11 C. parvum infection ......................................................................... 35 
3.2.11.1 In vitro infection ................................................................ 35 
3.2.11.2 C. parvum infection in mice............................................... 36 
3.2.12 Transfection ..................................................................................... 36 
3.2.12.1 Electroporation for MDBK transfection ............................ 36 
3.2.12.2 Electroporation for C. parvum transfection ....................... 37 
3.2.12.3 CpCDPK1 knock out through Cell penetrating peptide 
(CPP) - octaarginine mediated transfection ......................................... 38 
3.2.13 Geneticin screening for GFP-MDBK cells ...................................... 39 
3.2.14 Indirect immunofluorescent assay (IFA) ......................................... 39 
3.2.15 Animal feeding and body conditioning score (BCS) monitoring .... 40 
3.2.16 Faecal sample collection .................................................................. 43 
3.2.17 DNA extraction and oocysts per gram (OPG) determination of fecal 
samples ......................................................................................................... 43 
3.2.18 Statistical analysis ............................................................................ 44 
4. Results ................................................................................................................... 45 
4.1 CDPK1 knockout by REMI .................................................................... 45 
4.1.1 Construction of Knockout plasmid .................................................. 45 
4.1.2 Electroporation protocol and in vitro analysis ................................. 49 
4.2 CDPK1 knockout by CRISPR/Cas 9-mediated gene editing ................. 50 
4.2.1 Constructing CRISPR/Cas9_CpCDPK1_7 plasmid ........................ 51 
4.2.2 Amplification of CDPK1 flanked repair cassette ............................ 52 
4.2.3 Knockout CDPK1 via CRISPR/cas 9 .............................................. 53 
4.2.3.1 Electroporation and in vitro analysis ................................. 53 
4.2.3.2 CPP transfection and in vitro analysis ............................... 55 
4.2.3.3 Genetic assay of transfection ............................................. 57 
4.3 In vitro and in vivo model for infection and propagation ....................... 58 
4.3.1 In vitro model - C. parvum cultivation in COLO - 680 N cells ....... 58 
4.3.2 In vivo model Infection pattern of C. parvum in RAGgc x IFN-g KO 
mice    ........................................................................................................ 60 
4.3.2.1 Clinical symptoms ............................................................. 60 
4.3.2.2 Oocysts excretion ............................................................... 63 
Contents 
iii 
 
4.4 In vitro inhibition of CDPK1 .................................................................. 66 
4.4.1 Generating bAct-GFP-MDBK cells ................................................. 67 
4.4.2 Influence of CDPK1 inhibition on infection .................................... 70 
5. Discussion ............................................................................................................. 73 
5.1 Sub-cloning ............................................................................................. 73 
5.2 Inhibition of CpCDPK1 delays the host cell actin accumulation in vitro
 73 
5.3 RAGgc x IFN-gamma KO mice for C. parvum propagation.................. 76 
5.4 CpCDPK1 knockout by CRISPR/cas 9 .................................................. 79 
5.5 COLO-680 N cells are not suited to propagate C. parvum in vitro ........ 82 
6. Summary ............................................................................................................... 85 
7. Zusammenfassung................................................................................................. 87 
8. References ............................................................................................................. 89 
 
  
Contents 
iv 
 
  
Introduction 
1 
 
1. Introduction 
Cryptosporidium parvum is a protozoan parasite that causes diarrhoea in many 
host species worldwide. C. parvum invades the brush border of intestinal 
epithelial cells thus inducing maldigestion and malabsorption. In man, a lethal risk 
has been reported for immunocompromised hosts or young malnourished children.  
Calcium-dependent protein kinases (CDPKs) are believed to play critical roles in 
apicomplexan protozoa and appear to essentially contribute to accomplishment of 
the parasitic life-cycle. It has been demonstrated experimentally, that CDPK 
inhibitors (“bumped kinase inhibitors”, BKI) hamper parasite development in 
vitro and reduce parasite reproduction in the natural host of C. parvum 
(LENDNER et al. 2015). 
The main aim of the present study was to expand the knowledge about function of 
C.parvum CDPK1 in the invasion process. In order to assess the potential of this 
gene as target for anti-cryptosporidiosis drug development, two attempts to 
generate a CDPK1 knockout (CDPK1 KO) parasite strain were made. The first 
was restriction enzyme mediated integration (REMI). The KO plasmids were 
constructed and the electroporation pattern was established to generate CDPK1 
KO C. parvum. The other attempt was to disrupt the CDPK1 gene via 
CRISPR/cas-9 mediated transfection. In this process, plasmids were constructed 
and transfected into freshly excysted C. parvum sporozoites followed by 
subsequent microscopic analysis after infection of host cells. In addition, I also 
attempted to establish an in vitro continuous culture for the parasite in order to 
propagate potential transgenic parasites, using the newly-described oesophageal 
squamous-cell carcinoma cell line, COLO-680N. For a potential propagation of 
the parasite in vivo, the RAGgcxIFN-gamma KO mouse strain was investigated. 
Also, we assessed the role of CDPK1 in Parasite development using the 
bumped-kinase inhibitor (BKI) K-1294. Overall this study hint at an essential role 
for CDPK1 in the development of C. parvum and further support the potential of 
this gene as a major target for anti-cryptosporidiosis drug development.
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2. Literature Review  
2.1 Biology  
2.1.1 Systematics 
Since it has been discovered in 1907, the genus Cryptosporidium is classified in the 
phylum Apicomplexa, class Conoidasida, order Eucoccidioridahas and family 
Cryptosporidiidae (TYZZER 1907). However, the taxonomic placement of 
Cryptosporidium became controversial. Convictive molecular phylogenetic evidences 
propose the genus to belong to the class of Gregarinomorphea as a subclass 
Cryptogregaria rather than to the Coccidia (CAVALIER-SMITH 2014). Like many 
other species in the genus, C. parvum is an intestinal protozoan parasite and may 
occur in a variety of vertebrates worldwide and is responsible for moderate to severe 
diarrhea and fatal disease in immunocompromised adult or neonatal hosts (MOSIER 
and OBERST 2000; ZAMBRANO et al. 2014). The main hosts are young calves at 
the age of 7-12 days that get infected through oral intake of oocysts (LENDNER and 
DAUGSCHIES 2014).  
2.1.2 Life cycle 
C. parvum has a complex life cycle which includes both sexual and asexual stages 
(Fig.1). The development starts when the infectious sporulated oocysts are ingested 
by a susceptible host. The oocyst measures approximately 5 µm × 4.5 µm and 
contains four sporozoites. After excystation of the sporozoites in the small intestine, 
invasion of mucosal epithelial cells takes place. The further development leads to the 
formation of trophozoites, followed by differentiation and asexual multiplication of 
merozoites, differentiation into sexual stages (gamonts), and finally, after fertilization, 
the formation of zygotes. These develop either into thin-walled oocysts that are 
probably responsible for autoinfection, or to the thick-walled oocysts that are excreted 
with the faeces into the environment (LENDNER and DAUGSCHIES 2014).   
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Fig.1 Life cycle of Cryptosporidium (Image adopted from Lendner and 
Daugschies (2014). TW: thick-walled oocyst. tw: thin-walled oocyst. 
 
The life cycle of Cryptosporidium is peculiar. Cryptosporidum is completely 
enveloped by host cell membrane (“intracellular localization”), but Unlike other 
apicomplexan parasites, it does not penetrate the host cell membrane and thus does 
not invade the cytoplasm of the host cell (SIBLEY 2010; VALIGUROVA et al. 2007). 
Apical organelles (i.e., rhoptries, micronemes, and dense granules) are vesicular 
secretory organelles that are present in sporozoites and merozoites. These organelles 
have been demonstrated to be involved in the invasion process. Specifically rhoptries 
and micronemes have been implicated in host cell adhesion and entry. The discharge 
of these organelles triggers the following formation of a parasitophorous vacuole (PV). 
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Calcium is widely believed to be an important messenger participating in the complex 
mechanisms controlling the process of host cell invasion (CHEN et al. 2004). 
Attachment is the initial step of invasion. Filamentous actin and other actin-associated 
proteins from the host cell accumulate at the host-parasite interface during  
attachment (ELLIOTT and CLARK 2000). This is followed by a short phase of active 
movement of the parasite on the surface of the host cell (“gliding motility”). The 
host’s cell membrane then forms folds, enveloping the parasite gradually and 
eventually forming the PV. The PV is the particular niche where the parasite develops 
and appears to allow supply of essential nutrients from the host cells by forming a 
“feeder organelle” (CHEN et al. 2005; VALIGUROVA et al. 2008). 
2.1.3 Tenacity of oocysts  
The ovoid-shaped thick-walled oocysts of C. parvum are excreted with the faeces and 
are able to survive up to six months in the environment. The wall is a rigid protein 
rich layer that is covered by a lipid bilayer structure (LENDNER and DAUGSCHIES 
2014). It provides mechanical resilience and resistance against physical or chemical 
attack (DELLING et al. 2016). The oocyst shows strong resistance to common water 
disinfectants like chlorine and monochloramine (KING and MONIS 2007). Although 
C. parvum tolerate a wide range of temperature under natural conditions, it is 
vulnerable in extreme environments which leads to desiccation and freezing 
(MORIARTY et al. 2005; ROBERTSON and GJERDE 2004). Over 90% of oocysts 
in water were proven not to be able to survive at -22 °C for 152 h and none could stay 
viable after 4 h desiccation at room temperature (RT) (ROBERTSON et al. 1992). 
2.1.4 Excystation of oocysts and invasion of host cells 
Exposure to stomach acid, bile salt and host gastrointestinal temperature triggers 
excystation (CHEN et al. 2004). The process is regulated by many factors. Due to low 
gastric pH the outer layer of the ingested oocyst is degraded. Increased temperature 
and the influx of bile salts promote the activation of the sporozoites. Intestinal 
enzymes cooperate with proteases of parasite origin to disrupt the oocyst wall. As a 
consequence, the sporozoites are released and the invasion of the epithelial brush 
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border is initiated (LENDNER and DAUGSCHIES 2014). Within a short period of 5 
min after excystation invasion may be completed (FORNEY et al. 1999). 
The invasion by sporozoites includes several sequential steps: (1) Attachment to host 
cells, (2) invagination of the host cell membrane at the binding site and (3) formation 
of a parasitophorous vacuole (PV). Glycoproteins on the epithelia apical membrane 
and sporozoite surface such as galactose-N-acetylgalactosamine 
(Gal/GalNAc)-specific lectins are involved in C. parvum sporozoite attachment to 
host cells (CHEN and LARUSSO 2000). 
Gliding motililty is a phenomenon that is believed to be ubiquitously occurring in 
invasion of host cells by apicomplexan parasites (WETZEL et al. 2005). This type of 
movement does not depend on cilia or flagella, but relies on an actin-myosin motor 
beneath the parasite plasma membrane (SIBLEY 2004). Upon the binding of myosin 
to the inner membrane complex (IMC), the actin filaments are pushed backward 
resulting in the parasite moving ahead (LENDNER and DAUGSCHIES 2014). The 
gliding motility of C. parvum sporozoites is similar to that observed in other species 
of apicomplexa. Time lapse video showed that C. parvum can finish the invasion 
within 30 s which is faster than e.g. Toxoplasma gondii (WETZEL et al. 2005).   
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2.1.5 Formation of the PV 
The PV represents a bubble-like structure induced by apicomplexan parasites 
invading the host cell. It is bordered by plasma membrane thereby offering a vacuolar 
space for the parasite to develop within the cell (LALIBERTÉ and CARRUTHERS 
2008).  
In the case of C. parvum infection, the host cell undergoes massive morphological 
changes after the attachment of a sporozoite. The cell forms protrusions along the 
surface of the parasite. Then, an electron-dense band gradually emerges at the 
attachment area between the parasite and host cell.  After the parasite is fully 
covered, the feeder organelle is formed at the border between PV and  host cell 
(UMEMIYA et al. 2005).  
VALIGUROVA et al. (2008) suggest that “PV” is a misleading term to describe the 
unique structure that is created by Cryptosporidium spp. Because the PV indicates a 
vacuolar space with the boundary of membrane that isolates itself from the host cell 
(SCHOLTYSECK 1979). However, they found evidences that stood against this idea. 
Instead, they named it parasitophorous sac (PS) for the following reasons. (1) 
Cryptosporidium utilizes the membrane of the epithelial cells rather than its own 
plasma membrane to create this compartment. (2) A thin layer of host cell cytoplasma 
is found in the PS membrane fold. (3) incomplete fusion leads to openings in the PS 
membrane that are believed to connect the internal to the external environment of the 
parasite (UMEMIYA et al. 2005). (4) PS leaves a small gap between host cell and the 
parasite. (5) The PS is separated into modified and unmodified parts by an 
electron-dense band at the parasite-host interface (VALIGUROVA et al. 2008). 
However, despite these arguments PV is still the commonly used term to describe the 
intracellular location of the parasite.   
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2.1.6 Nutrient supply by the host  
The mechanisms of how Cryptosporidium derives nutrients from the host cell remain 
unclear. The feeder organelle is believed to play the key role for nutrients intake 
during intracellular parasite development. It displays an extensively folded surface 
which dramatically increases the surface of the contact area between host cell and 
parasite (BOROWSKI et al. 2008; CAVALIER-SMITH 2014). In addition, 
transporters on the PV membrane are also essential, as 69 transporters have been 
detected on surface of freshly excysted sporozoites. They were demonstrated to serve 
functions of substrate acquisition including fatty acids, amino acids and nucleotides 
(THOMPSON et al. 2005; SANDERSON et al. 2008; YAMAGISHI et al. 2011). 
The fatty acid beta-oxidation pathway does not seem to play the role of energy 
gaining in C. parvum since no genes related to Krebs cycle were found in the genome 
(ABRAHAMSEN et al. 2004). The main energy pathway appears to be glycolysis and 
the energy is probably stored in polysaccharides. The existence of enzymes associated 
with production and degradation of polysaccharides strongly supports this assumption 
(HARRIS et al. 1999; THOMPSON et al. 2005).   
Fatty acid is believed to be generated by the type I fatty acid synthetase and a 
long-chain fatty acid enlongase-mediated system in C. parvum (ZHU 2004; 
FRITZLER et al. 2007). However, these two enzymes only endow the parasite with 
the ability of chain enlongation, not de novo biosynthesis of fatty acid. Therefore, it is 
very likely that C. parvum gains the basic substrate from the host cell. So far, no 
transporters but only three fatty acyl synthases have been demonstrated to potentially 
serve this function (ZHU et al. 2004; ZENG et al. 2006; ZENG and ZHU 2006).   
Amino acids are also not de novo synthesized by Cryptosporidium, but acquired from 
the host as well. At least 11 transporters have been found on PV membrane associated 
to amino acid acquisition (ABRAHAMSEN et al. 2004). The parasite is able to 
convert several amino acids from one to another such as, serine to glycine and 
aspartate to asparagine (RIDER and ZHU 2010).  
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Polyamines are generated from arginine by C. parvum using a plant-like arginine 
decarboxylase rather than ornithine decarboxylase which is regularly seen in 
mammalian cells (KEITHLY et al. 1997).  
 
2.2 Epidemiology  
2.2.1 Human Cryptosporidiosis 
It is widely known that Cryptosporidium infection can be lethally dangerous to 
individuals carrying human immunodeficiency virus (HIV) due to the deficiency of 
the immune system. Moreover, severe Cryptosporidium infection may also be 
associated to hepatitis B virus (HBV) infection in man (YANG et al. 2017) which 
probably is likewise associated to a compromised immune system (FERRARI 2015). 
The predominating transmission of cryptosporidiosis to humans is by oocyst 
contaminated water or food. Besides, direct contact with infected hosts may also 
cause infection. The disease causes large economic losses in animal husbandry and 
threats to public hygiene worldwide. In 1993, a massive waterborne outbreak was 
reported in Milwaukee in which over 400,000 persons were infected.  Such a 
massive transmission was ascribed to the contamination of public water supply 
(MACKENZIE et al. 1995) . 
Throughout the world thousands of children younger than 5 years old die due to 
cryptosporidiosis annually. Most cases are reported from less developed countries in 
Africa and Asia. Malnutrition and undergrowth are associated to the infection and are 
commonly seen in these areas (MONDAL et al. 2009; MOLBAK et al. 1997).   
Young livestock, especially calves, are frequently infected by C. parvum and are 
regarded an important infection source for humans (LENDNER and DAUGSCHIES 
2014). Persons, particularly children, who live in close contact with young ruminants 
or drink surface water that is contaminated with ruminant faeces have a higher risk of 
infection (KOTLOFF et al. 2013; HELMY et al. 2015).  
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More than 15 species of Cryptosporidium are known to be potentially infectious to 
humans. C. hominis and C. parvum are the most frequently detected zoonotic species 
(CHECKLEY et al. 2015). C. hominins is found in humans ubiquitously, especially in 
developed countries, whereas the majority of human cases of infection in the Middle 
East and many developing regions are attributed to C. parvum. In Europe, however, 
both are observed (XIAO 2010). In Germany, human cryptosporidiosis is a rather rare 
disease with approximately 1000 documented cases annually since this disease 
became notifiable in 2002. It appears, however, rather probable that the number of not 
notified cases is much higher. In 2012, an almost 5 fold sudden increase of prevalence 
was reported for unknown reasons simultaneously in the Netherlands and the United 
Kingdom (FOURNET et al. 2013). In young animals and water bodies, 
Cryptosporidium is widely distributed form the north to the south of Germany with 
the zoonotic C. parvum generally dominating (KARANIS et al. 1998; BROGLIA et al. 
2008; AJONINA et al. 2012).  
2.2.2 Animal Cryptosporidiosis 
Cryptosporidium is a ubiquitous parasite in domestic animals and wildlife. Ruminants 
are the most common hosts. In cattle, C. parvum, C. bovis, C. andersoni, and C. 
ryanae are recorded as the four most common species (XIAO and FENG 2008; XIAO 
2010). Only C. parvum is considered pathogenic for young ruminants and to be of 
zoonotic impact while the other 3 species are rarely seen in humans (XIAO AND 
FENG 2008). In sheep, the prevalence of Cryptosporidium spp. ranges from < 5% up 
to > 70% upon distribution worldwide (ROBERTSON 2009). So far, at least eight 
species of the genus Cryptosporidium have been detected in sheeps globally, but only 
three species are claimed to be related to health problems, and they dominate 
diversely in different areas as follows; C. parvum in Europe, C. xiaoi in Australia, and 
C. ubiquitum in America and Asia (RYAN et al. 2014). C. parvum, C. hominis, C. 
ubiquitum and C. xiaoi have also been identified in goats (GEURDEN et al. 2008; 
DÍAZ et al. 2010; FAYER et al. 2010). 
Literature Review 
10 
 
In pigs, C. suis and C. scrofarum have been reported to be the two most common 
species globally (YIN et al. 2011; NĚMEJC et al. 2013; YUI et al. 2014). Similar to 
the cases in calves, the infection appears to be age-related. That is to say, the parasite 
is more commonly detected in pre-weaned piglets than in adults (ZHANG et al. 2013; 
YUI et al. 2014). Dogs and cats have been found to host C. canis,  C. felis, C. 
parvum, and C. muris (PALMER et al. 2008; LUCIO-FORSTER et al. 2010). 
Cryptospordium spp. were first identified in rabbits as a genotype that was later 
accepted as a separate species, C. cuniculus, in the Czech Republic (RYAN et al, 
2003). It has both zoonotic and anthroponotic features and occurs in Europe and 
Africa (CHALMERS et al. 2009; MOLLOY et al. 2010). C. meleagridis, C. baileyi, 
and C. galli are recognized to be bird specific species of the genus Cryptosporidium. 
Except for C. meleagridis, which is regarded zoonotic, the other two species have no 
respective impact for humans (RYAN et al. 2014). Reptiles and amphibia, toads, 
snakes, lizards and tortoise are reported to host C. fragile, C. serpentis, C. varanii and 
C. ducismarci, respectively (JIRKU et al. 2008; XIAO et al. 2004; TRAVERSA 
2010). 
Compared to the species in terrestrial hosts, far less is known about cryptosporidia in 
aquatic animals. Seals and fishes have been reported to host C. muris and C. molnari, 
respectively (SANTÍN et al. 2005; RENGIFO-HERRERA et al. 2011; 
ALVAREZ-PELLITERO and SITJÀ-BOBADILLA 2002). Oocysts of C. parvum and 
C. hominis have been isolated from clams, mussels, cockles, and oysters 
(ABRAHAMSEN et al. 2004; STAGGS et al. 2015; TRAVERSA et al. 2004). 
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2.3 Detection and Diagnosis  
Cryptosporidiosis should be suspected in hosts who undergo acute gastroenteritis or 
prolonged diarrhea. The diagnosis includes clinical consultation, fecal specimen 
sampling, microscopic testing and reporting (TAM et al, 2012). 
Various methods have been developed to detect cryptosporidiosis in fecal samples. 
Microscopy of acid fast (AF)-modified Ziehl-Neelsen staining is one of the most 
commonly used methods. The oocysts are stained red against the blue background 
(STARK et al. 2009). The negative staining technique of Heine is another routine 
microscopy method to detect Cryptosporidium spp. which is easy and widely 
distributed with lower sensitivity than modified Ziehl-Neelsen staining 
(POTTERS and VAN ESBROECK 2010). However, microscopy is not very 
sensitive and may deliver false negative results, particularly in cases of low infection 
and sporadic shedding (CLAVEL et al. 1995).  
Higher sensitivity is obtained by direct or indirect immunofluorescence assay (DFA / 
IFA). However, these methods are rather expensive and  demand availability of a 
fluorescence microscope (CHALMERS et al. 2011).  
Enzyme-linked immunosorbent assay (ELISA), enzyme immunoassay (EIA) and 
immunochromatography have been developed and commercial kits are available. The 
tests are easy to perform and do not need special laboratory equipment. However, the 
sensitivity varies a may range from 70% -100% (GARCIA and SHIMIZU. 1997; 
JOHNSTON et al. 2003; YOUN et al. 2009). 
Molecular tests have also been used for detection of this parasite in faeces or/and 
water samples, such as polymerase chain reaction (PCR) and loop mediated 
isothermal amplification (LAMP) (KAUSHIK et al. 2008; PLUTZER and KARANIS 
2009).  
Recently, a study performed by MIRHASHEMI et al. (2015) compared the specificity 
and sensitivity of four detection methods (acid-fast staining, ELISA, DFA and PCR) 
in cattle, sheep and horse, respectively. The authors concluded that the optimal way is 
to combine DFA and PCR. PCR showed the highest sensitivity and specificity in 
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sheep and horse samples, whilst DFA was the best in cattle samples. Real-time PCR 
has been reported to show higher sensitivity than DFA and, as expected, was more 
accurate in terms of quantitative determination. Furthermore, quantitative PCR is also 
capable of revealing correlation between the diarrhea severity and oocyst  excretion 
(OPERARIO et al. 2015). Particularly for examination of environmental probes PCR 
appears to be the most frequently applied method (STINEAR et al. 1996; 
HALLIER-SOULIER and GUILLOT 2000; HONG et al. 2014). 
High sensitivity is not the only advantage of PCR. Its capability to distinguish 
Cryptosporidium spp.in clinical and environment samples is outstanding as well 
(CHALMERS and KATZER 2013). For sub-genotyping the 60-kDa glycoprotein 
(gp60) gene is the most widely used marker (ZAHEDI et al. 2016). 
 
2.4 Treatment options  
The lack of satisfactory treatment is a considerable concern that researchers are 
currently devoting themselves to. Numerous drugs have been tested and ended up in 
failure of cure. To date, only one FDA-approved drug, nitazoxanide (NTZ), is 
available for treatment of persons suffering from cryptosporidiosis. It is partially 
effective in children and immunocompetent hosts, but it is completely ineffective in 
AIDS patients (AMADI et al. 2009). Paromomycin, an aminoglycoside antibiotic, 
was reported several times to have the capability of inhibiting Cryptosporidium to a 
certain extent in man, animals and in vitro (TZIPORI et al. 1994a; GRIFFITHS et al. 
1998a; CAI et al. 2005). So far, NTZ and paromomycin are the most widely used 
drugs in a large variety of livestock including ruminants, pigs, horses, house pets (cats 
and dogs) and birds (VIU et al. 2000; VAN ZEELAND et al. 2008; SCHNYDER et al. 
2009; TZIPORI et al. 1994a; SCORZA AND Lappin 2007; ROBINSON et al. 2008).   
Halofuginone has been reported to control C. parvum in vitro (NAJDROWSKI et al. 
2007). More importantly, it is efficient in calves by effectively reducing oocyst 
shedding and diarrhea (BOROWSKI et al. 2008; JARVIE et al. 2005; JOACHIM et al. 
2003; KEIDEL and DAUGSCHIES 2013; LEFAY et al. 2001). TROTZ-WILLIAMS 
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et al. (2011) confirmed the reduction of oocyst shedding. More importantly, they 
observed significant correlation between the diarrhea delay and the use of 
halofuginone.  
It was suggested that decoquinate is able to prevent and control cryptosporidiosis in 
pre-weaned calves (HOBLET et al. 1989). In contrast, MOORE et al. (2003) stated 
that decoquinate has no effect on oocyst shedding or clinical signs in calves infected 
with C. parvum. Despite both halofuginone and decoquinate do not provide complete 
cure, the effectivity of halofuginone and decoquinate has been compared. The results 
showed that halofuginone performed better in reduction of oocysts excretion, while 
decoquinate improved the daily weight gain of calves (LALLEMAND et al. 2006). 
Activated charcoal with wood vinegar liquid has been proposed to be effective in 
prevention and controlling of cryptosporidiosis in both calves and lambs, since it 
reduced oocysts excretion and diarrhea (WATARAI et al. 2008; PARAUD et al. 
2011).  
Combined uses of different drugs have been suggested to be more effective against 
cryptosporidia. In AIDS patients, treatment with paromomycin alone or in 
combination with azithromycin was proven protective against Cryptosporidium 
(MEAMAR et al. 2006). The combined use of norfloxacin and clopidol may help in 
prevention and treatment of cryptosporidiosis in chicken while this is not the case if 
they are used as single drugs (EL-SHAFEI et al. 2014).  
Bovine hyperimmune colostrum and antibody containing egg yolk were found useful 
in mammals to various extents (NORD et al. 1990). Neonatal lambs receiving 
hyperimmune colostrum showed less mortality and stronger resistance (NACIRI et al. 
1994). Oral bovine serum concentrate (BSC) relieves symptoms of cryptosporidiosis 
such as peak diarrhea volume, intestinal permeability, oocysts excretion and recovery 
of villous surface area in calves (HUNT et al. 2002). Oral application of 
serum-derived bovine immunoglobulin (SBI) controlled diarrhea caused by 
Cryptosporidium and Norovirus in organ transplant patients (GELFAND and 
CLEVELAND 2017).   
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Inhibiting the function of various enzymes of Cryptosporidium is a novel perspective 
for treatment. A cysteine protease inhibitor, K11777, eliminates C. parvum infection 
from cell lines in vitro and rescues mice from an otherwise lethal infection with the 
parasite (NDAO et al. 2013). A pyrazolopyrimidine-based compound, named BKI 
1294, that acts as a calcium dependent protein kinase 1 (CDPK1) inhibitor, has been 
reported as a promising lead for the development of drugs for treatment of 
cryptosporidiosis. It was determined to possess significant curative effect against 
Cryptosporidium both in vitro and in vivo (CASTELLANOS-GONZALEZ et al. 2013; 
LENDNER et al. 2015).  
The Cryptosporidium inosine 5’-monophosphate dehydrogenase (CpIMPDH) enzyme 
is critical for the parasite to survive in the host cell, as it provides the ability of purine 
salvage from the host. Eight CpIMPDH inhibitors have been investigated in vitro, and 
two compounds, named as P96 and P131, ended up as potential candidates supposed 
to control clinical infection (GORLA et al. 2014). 
LOVE et al. (2017) screened 12 potential drugs including antibiotics and protein 
inhibitors by using a high-content imaging phenotypic assay to identify whether they 
have anticryptosporidial activity. As a result, only one out of twelve candidates was 
identified to have a potential as a drug for treatment of cryptosporidiosis. Unlike other 
candidates, clofazimine (CFZ), a FDA approved drug for treatment of leprosy, 
showed no toxicity-related undesirable effects to mammalian cells in vitro. The 
authors suggested that CFZ is worth to be studied as a potential new treatment of 
cryptosporidiosis in further investigation. 
 
2.5 Hygiene 
As the infection requires the direct contact with oocyst of the parasite, avoiding the 
exposure of the host to the pathogen is essential for any control measure.  
A clean water source is of utmost importance. For humans, the water quality of tap 
water and swimming pools must be strictly monitored, because these two are the main 
routes of transmission of human cryptosporidiosis, and they could be contaminated by 
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surface water bodies (WIDERSTRÖM et al. 2014; JACOB et al. 2015). For animals, 
the environmental contamination is commonly the fundamental source of infection. 
Oocysts may be distributed in drinking water, feed, slurry, or on the surface of stables 
or skin of infected animals which may all possibly result in oral oocyst uptake by 
drinking, feeding or licking. Therefore, proper hygienic management is particularly 
important in husbandry (FAYER et al. 2004; KEIDEL and DAUGSCHIES 2013). 
SHAHIDUZZAMAN and DAUGSCHIES (2012) summarized following 
recommendations. (1) A duration of at least 7 days of quarantine needs to be applied 
when newly purchased animals arrive. (2) Coproscopy needs to be carried out for 
Cryptosporidium in animals that are under suspicion. (3) Stables and related 
equipment need to be properly cleaned and disinfected. (4) A suitable drug needs to 
be administrated in case of infection. 
Many studies about inactivation of Cryptosporidium oocysts using various methods 
were published. Thermal treatment of oocysts for 20 min achieves complete 
inactivation at 56°C or more (SHAHIDUZZAMAN et al. 2010). Exposure to UV 
light was also demonstrated to be effective (>99% inactivation) if applied for 30 min 
(CLANCY et al. 2004; DELLING et al. 2016). Over 98% inactivation of oocysts was 
observed with at least 2% concentration of cresol based disinfectants applied for 2 h  
while 6% sodium hypochlorite induced an inactivation rate of 92.7%  
(SHAHIDUZZAMAN et al. 2010). Formaldehyde and hydrogen peroxide were both 
reported to have anticryptosporidial activity (WEIR et al. 2002; CASTRO-HERMIDA 
et al. 2006). Neopredisan
®
 135-1 and Aldecoc
®
 TGE, two commercial disinfectants 
appointed by the German Veterinary Society (DVG), are able to inactivate more than 
99.5% of oocysts at a concentration of 2% and 4%, respectively 
(SHAHIDUZZAMAN et al. 2010). At the same contact time of 2 h 3% KENO
TM
 
COX, a amine based disinfectant, also has the ability to eliminate the infectivity of 
oocysts (NACIRI et al. 2011). 
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2.6 Vaccine  
The mechanism of the interaction between the host immune system and 
Cryptosporidium remains unclear (PANTENBURG et al. 2008) and no efficient 
vaccines have been developed so far. Several antigens have been taken into account. 
However, limited protection and susceptibility of vaccinated animals to reinfection 
was reported (MEAD 2010; SHEORAN et al. 2012; PREIDIS et al. 2007). Vaccines 
containing irradiated or genetically modified cryptosporidia are likely to be the most 
promising paths to achieve effective protection (STRIEPEN 2013; MEAD 2014). 
Since the localization of the parasites in host is the intestinal mucosa, strengthening of 
the mucosal immune system seems to be the only option to induce sufficient 
protection by vaccines (MEAD 2014). 
2.7 In vitro and vivo Models  
In vitro completion of the life cycle of C. parvum was reported in an axenic system 
(HIJJAWI et al. 2004); however, another group failed to reproduce this observation 
(GIROUARD et al. 2006). In a recent study three life cycle stages (sporozoites, 
trophozoites and type I merozoites) of C.parvum were identified in an axenic culture 
by scanning electron microscopy (SEM) (YANG et al. 2015). In the same study, 
delayed and depressed expression of sporozoite surface antigen protein (cp15) and 
Cryptosporidium oocyst wall protein (COWP) was observed. The authors suggest that 
these phenomena may explain delayed development of new oocysts in axenic culture 
(YANG et al. 2015). In another study, C. parvum multiplied 2–3 fold after six days of 
cultivation on an aquatic biofilm and developed various stages including sporozoites, 
trophozoites, type I and II meronts (KOH et al. 2013). 
Various cell culture types and animal models have been applied to study C. parvum. 
Abundant cell lines, such as the human ileocecal adenocarcinoma cell line (HCT-8), 
heterogeneous human epithelial colorectal adenocarcinoma cell line (Caco-2), 
Madin-Darby canine kidney cell line (MDCK), Madin-Darby bovine kidney cell line 
(MDBK) and a human, non-carcinoma, small intestinal epithelial cell line, named FHs 
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74 Int have been used (VARUGHESE et al. 2014).  Immortalized cell lines are most 
commonly used, particularly HCT-8 (UPTON et al. 1994).  
Cell lines have been studied for propagation of C. parvum as well as tools for 
investigation of the parasite’s biology. It was observed that C. parvum could display 
its whole life cycle in a HCT-8 cell culture system, and no significant difference in C. 
parvum multiplication was seen between cell culture and axenic culture 
(PAZIEWSKA-HARRIS et al. 2016). COLO-680N cells have been recently described 
to be also suitable for C. parvum propagation as they produced sufficient infectious 
oocysts to infect subsequent cultures (MILLER et al. 2017). 
Despite the evidence of successful in vitro propagation to date, none of the reported 
systems delivers enough oocysts to replace propagation in vivo. Of course, animal 
models are essential if clinical signs of infection and drug efficacy have to be 
recorded. Young ruminants such as suckling calves are very suitable for propagation 
of C. parvum since they excrete large amounts of oocysts (NYDAM et al. 2001). 
Piglets have been studied as well to test parasite pathogenicity and drug efficacy 
(ENEMARK et al. 2003; TZIPORI et al. 1994b).  
Many experimental studies have been reported in laboratory rodent models, especially 
in mice. Suckling rats were used as the model to investigate the efficacy of probiotics 
against C. parvum (GUITARD et al. 2006). Suckling rats were also used to 
demonstrate the mechanism of amino acid malabsorption caused by C. parvum  
(TOPOUCHIAN et al. 2001 and 2003). Susceptibility of mice to C. parvum is 
increased in animals with reduced immunity. Thus various attempts to propagate C. 
parvum in immunodeficient mice have been reported, including neonatal mice, early 
weaned mice, malnourished mice and artificially immunocompromised mice 
(LACROIX et al. 2001; COSTA et al. 2011; COSTA et al. 2012). Interferon-gamma 
knock out (GKO) mice are highly sensitive to C. parvum and suitable as a model for 
drug screening (GRIFFITHS et al. 1998b). Dexamethasone-treated and thus 
immunosuppressed CF-1 mice are recognized as a better animal model than C57BL/6 
mice in producing high numbers of C. parvum oocysts (WARE and VILLEGAS 
2010). 
Literature Review 
18 
 
 
2.8 Structure and function of Calcium-dependent protein kinases 
Calcium-dependent protein kinases (CDPK) belong to a superfamily which consists of 
several types of the enzyme (CDPK 1 to CDPK12). Their activity is regulated by 
calcium and involves a set of intracellular cascade reactions (HARPER and 
HARMON 2005). CDPKs play critical roles in the calcium signaling pathway in 
plants, ciliates and apicomplexan parasites, they are not expressed in higher 
organisms and thus believed to be potential antiprotozoal drugs with no or minor side 
effects (HARPER and HARMON 2005).  
Twelve subtypes of CDPK have been characterized in various organisms, so far. 
Though the various types of the superfamily differ more or less in structure and 
function, most of them share a similar structure with four domains: a variable 
N-terminal domain, a catalytic domain, a junction domain containing an 
autoinhibitory segment, and a calmodulin-like domain (Fig. 2) (HARMON et al. 
2000). They have four EF-hands with the Ca
2+
 binding sites that promote the 
activation process in the calmodulin-like domain. As the activation demands the 
cooperation of the junction domain and the calmodulin-like domain, the two parts are 
collectively named as the CDPK activation domain (CAD). After binding with Ca
2+
, a 
series of structural shifting is triggered including bending, folding and twisting, hence 
the message carried by Ca
2+
 accomplished transduction.  
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Figure 2. General structure of CDPK (HARMON et al. 2000). Two pairs of two 
EF-hands are triggered by Ca
2+
 binding to change conformation thus 
blocking the autoinhibitory domain. Thus the substrate binding site of the 
catalytic domain is made accessible to substrate binding and enzymatic 
activity is induced. 
 
The abundant variety of CDPKs indicates physical inconsistencies among the 
subtypes of this family. Different CDPKs are found located at different cellular 
positions, including the cytosol, nucleus, plasma membrane (HARPER et al. 2004). 
Furthermore, they may show different response to different calcium ion forms (LEE 
et al. 1998). In vitro it was shown that the expression of CDPK in C. parvum 
(CpCDPK) is stage specific (ETZOLD et al. 2014). This superfamily of enzymes can 
control a large array of physiological processes precisely without any unexpected 
crosstalk (GEISLER and VENEMA 2011).   
CDPKs have been extensively studied in other apicomplexans e.g. Toxoplasma gondii 
and Plasmodium falciparum (LIM et al. 2012; SUGI et al. 2010). In T. gondii, 
elevated intracellular calcium promotes multiple activities such as motility and 
invasion by stimulating the secretion of micronemes. On the contrary, decline of the 
Ca
2+
 concentration effectively inhibits cell invasion by the parasite (CARRUTHERS 
et al. 1999; CARRUTHERS and SIBLEY 1999). CDPKs transduce the information 
from the second messenger, intracellular Ca
2+
, to the organelles and then trigger a set 
of processes that affect cellular features. For instance, CDPKs are reported to regulate 
cytoskeletal dynamics and motor complexes (BILLKER et al. 2009). In Plasmodium, 
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several studies suggest that invasion, motility, discharge of organelles and sexual 
differentiation are all regulated by the level of Ca
2+
 (BILLKER et al. 2004; ISHINO 
et al. 2006; VAID et al. 2008; ONO et al. 2008). It appears likely that this is related to 
CDPK, as well as discharge of micronemes during invasion supposed to occur in  
Cryptosporidium similarly to other apicomlexans (SHARMA and CHITNIS 2013).
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3. Animals, materials and methods 
3.1 Animals and materials 
3.1.3 Mice 
RAGgc (recombination activating genes common gamma chain) x IFN-gamma 
(interferon gamma) KO (knockout) mice  
3.1.4 Cells 
Table 1. Cells used in the study.  
Cell lines for in vitro infection HCT-8 cells 
COLO-680N cells 
MDBK cells 
E. coli for cloning XL1-Blue
®
 competent cells 
(Stratagene, San Diego) 
 
3.1.5 C. parvum oocysts 
C. parvum oocysts (in house strain LE-08-Cp-08) 
3.1.6 Reagents  
Table 2. Reagents used in the study. 
Reagents for cell culture and in vitro infection 
PBS (phosphate buffered saline)  
RPMI 1640 medium (Thermo Fisher Scientific, Waltham) 
DMEM medium (Thermo Fisher Scientific, Waltham) 
NaT(Sodium taurocholate hydrate) (Sigma-Aldrich, Hamburg) 
G418 (Thermo Fisher Scientific, Waltham) 
Reagents for molecular biology  
Agarose (Roth
®
; Karlsruhe, Germany) 
TBE (Tris-Borate-EDTA) (AppliChem, Darmstadt) 
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GeneRuler 100 bp Lader (Thermo Fisher Scientific, Waltham) 
GeneRuler 1kb DNA Ladder (Thermo Fisher Scientific, Waltham) 
Dream Taq buffer 10X with MgCl2 (Thermo Fisher Scientific, Waltham) 
DreamTaq DNA Polymerases (Thermo Fisher Scientific, Waltham) 
dNTPs (Thermo Fisher Scientific, Waltham) 
TaqMan
®
 qPCR Master Mixes (Thermo Fisher Scientific, Waltham) 
SOC (Thermo Fisher Scientific, Waltham) 
LB-Agar (Lennox) (Carl Roth, Karlsruhe) 
LB-Medium (Lennox) (Carl Roth, Karlsruhe) 
FastDigest AatII (Thermo Fisher Scientific, Waltham) 
FastDigest AvrII (XmaJI) (Thermo Fisher Scientific, Waltham) 
FastDigest NdeI (Thermo Fisher Scientific, Waltham) 
FastDigest NheI (Thermo Fisher Scientific, Waltham) 
FastDigest MluI (Thermo Fisher Scientific, Waltham) 
BbsI-HF (New England Biolabs
®
 Inc, Ipswich) 
T4 Polynucleotide Kinase (New England Biolabs
®
 Inc, Ipswich)  
CIP (New England Biolabs
®
 Inc, Ipswich) 
Reagents used in animal experiment  
Metamizol (Ratiopharm, Ulm) 
Glucose (Carl Roth, Karlsruhe) 
Reagents for IFA 
Glycine (Carl Roth, Karlsruhe) 
PFA (Paraformaldehyde) (Sigma-Aldrich, Hamburg) 
Triton X-100 (Carl Roth, Karlsruhe)  
BSA (bovine serum albumin) (Carl Roth, Karlsruhe)  
Antibodies and fluorescent dyes 
Rat anti-Crypto (Waterborne, New Orleans) 
Dylight
TM
 647 anti rat IgG (H&L) (Rockland, Limerick) 
DyLight
TM
 488 anti-rat IgG (Rockland, Limerick) 
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DAPI (Thermo Fisher Scientific, Waltham) 
Mouse anti-NPTII (Alpha Diagnostic International, San Antonio) 
Crypto-a-glo (Waterbone, New Orleans) 
Fluoromount-G (Thermo Fisher Scientific, Waltham) 
 
3.1.7 Plasmids and oligonucleotides 
3.1.7.1 Plasmids 
Plasmids used in order to construct CDPK1 knock out plasmid via sub cloning are 
shown in Fig 3.  
 
Figure 3. Plasmids (backbone vector pSC-A) for construction of C. parvum 
CDPK1 knock out plasmid. *The plasmids are denominated as pA, pB, pC and 
pD respectively as shown above.  
 
Table 3. Plasmids supplied by researchers from other institutes. 
Plasmid Denomination Provider 
pCpact5’mcherryEtact3’ pmCherry Anne-Kristin Teten (Institut für 
Zoologie, Technische 
Universität Dresden) 
Aldo Cas9 Ribo + U6 p185 Boris Striepen (Pathobiology, 
University of Pennsylvania 
School of Veterinary Medicine) 
Enoprom_Nluc_neo_enoutr P71 
pCAG-mGFP-Actin pGFP-Actin Addgene 
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3.1.7.2 Primers and probes 
Table 4. Primers used in the study 
5UTR’_Cp
CPDK1F 
CGCCATATGGCGACTCGGAATTTATTTTTTCCTTCG 
5UTR’_Cp
CPDK1R 
CGCGACGTCGCGTTATAACAAGCCTTAATTGTGAGT 
hsp_70F AACTTTAGCTCCAG TTGAGAAGTACTC 
hsp_70R CATGGCTCTTTACCGTTAAAGAATTCC 
HSP_70_S
NA 
AATACGTGTAGAACCACCAACCAATACAACATC 
CpCDPK1_
181 F 
GTTGGACTGGTATGTTTGTTCAGAG 
CpCDPK1_
181 R 
AAACCTCTGAACAAACATACCAGTC 
CpCDPK1_
7 F 
GTTGGAATACTGCAGTAGGGAATAC 
CpCDPK1_
7 R 
AAACGTATTCCCTACTGCAGTATTC 
gRNA 
screening 
primer  
CTTTACTATTTATTCCGCTTCCACATGC 
Seqp185 F CTTTACTATTTATTCCGCTTCCACATGC 
CDPK1koF 
ATTTTAGTTCAGGAATAATCCAAACAACTCACAATTAAGGCT
TGTTATAATGGGGAAACTAAATATACTG 
CDPK1koR 
TCAGAAGAATTCGTCAAGAAGACTACTCTCAAATAGTAGTG
AACTCTATATATTTCAATTCTATTATTATTA 
The under lined base pairs in primers represent for the overhangs compatible to 
restriction site Bbs I. Letters in red represent for the manually added base pairs 
when the corresponding gRNA does not start with “G”.  
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3.1.8 Kits 
GeneJET Gel Extraction Kit (Thermo Fisher Scientific, Waltham) 
GeneJET PCR Purification Kit (Thermo Fisher Scientific, Waltham) 
T4 DNA Ligase Kit (Thermo Fisher Scientific, Waltham) 
GeneJET Plasmid Miniprep Kit (Thermo Fisher Scientific, Waltham) 
GeneJET Plasmid Maxiprep Kit (Thermo Fisher Scientific, Waltham) 
Qiagen Maxiprep kit (Qiagen, Hilden) 
NucleoSpin
®
 DNA Stool Kit (Macherey-Nagel GmbH & Co.KG, Düren) 
3.1.9 Instruments and software 
Mikro 200 (Hettich, Tuttlingen) 
Centrifuge5810 R (Eppendorf, Hamburg) 
Mini Incubator (Bode, Berlin) 
Incubator BD 260 (Binder, Tuttlingen) 
Incubator Hood TH 15 (Edmund Bühler, Bodelshausen) 
Mx3000P qPCR System (Stratagene, San Diego) 
Hera safe KS12 Class II Biological Safety Cabinet (Thermo Fisher Scientific, 
Waltham) 
ECM 830 square wave electroporator (BTX, Holliston) 
Gene Pulser Xcell™ (Bio-rad, Hercules) 
TCS SP8 system (Leica, Wetzlar) 
Fluorescent microscope DM IRB (Leica, Wetzlar) 
FACS Aria™ III (Becton Dickinson, Heidelberg) 
Bandelin sonopuls GM70 (Bandelin, Berlin) 
FACSDiva™ V6.5 (Becton Dickinson, San Jose) 
SPSS (IBM, New York) 
Genenious (Biomatters, Auckland) 
Imaris (Bitplane, Zurich) 
ArgusX1 (Biostep, Burkhardtsdorf) 
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3.2 Methods 
3.2.1 Preparation of reagents  
PBS 
10 x concentrate PBS stock was prepared by dissolving 1,4 M NaCl, 30 mM KCl, 40 
mM Na2HPO4 and 20 mM KH2PO4 in ddH2O. Prior to use, 1 x PBS was prepared 
by diluting in ddH2O and pH was adjusted to 7.4. 
Growth medium for HCT-8 and COLO-680N cells 
RPMI 1640 medium (Thermo Fisher Scientific, Waltham) complemented with 10% 
FCS, 1% P/S, 1% Ampho B and 1% Napy.  
Growth medium for MDBK cells 
DMEM medium (Thermo Fisher Scientific, Waltham) complemented with 10% FCS, 
1% P/S, 1% Ampho B.  
Infection medium 
Corresponding medium completed with 2% FCS, 1% P/S, 1% Ampho B and 1% 
Napy. 
Excystation buffer 
1.2 % NaT dissolved in growth medium and stored at 4℃ for maximum one week. 
Prior to use, dilute the stock with growth medium at the ratio of 1:3. 
1.5% Agarose-Gel 
375 g Agarose (Carl Roth; Karlsruhe) powder dissolved in 250 ml 1 x TBE buffer 
(AppliChem, Darmstadt), heated in microwave oven prior to use. 
LB agar  
35g LB-Agar (Lennox) powder (Carl Roth, Karlsruhe) was dissolved in 1 L ddH2O 
and autoclaved, then split in to petri dish and stored at 4 ℃. 
LB medium  
20 g LB-Medium (Lennox) powder (Carl Roth, Karlsruhe) was dissolved in 1 L 
ddH2O and autoclaved. Stored at 4 ℃. 
Incomplete cytomix buffer 
10mM K2HPO4/KH2PO4, 120mM KCl, 0.15mM CaCl2, 25mM HEPES, 2mM EGTA 
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and 5mM MgCl2 dissolved in ddH2O and pH was adjusted to 7.6.  
Complete cytomix buffer 
Incomplete cytomix buffer complemented with 2mM ATP and 5mM glutathione. 
Fixation solution 
20 g of PFA powder dissolved in 500 ml in pre-heated PBS. 
Permeabilization solution 
200 µl Triton X-100 dissolved in 100 ml PBS 
Blocking buffer 
Permeabilization solution completed with 2% BSA 
 
3.2.2 C. parvum oocysts maintaince  
C. parvum oocysts were stored in PBS at 4 °C. The parasite strain is maintained by 
passage through calves approximately every 3 months. Calves are infected orally with 
C. parvum oocysts. Diarrheal stools were collected and washed by ether and 
centrifugation. Oocysts were isolated by saturated-salt solution flotation and stored in 
PBS.  
 
3.2.3 PCR 
3.2.3.1 Amplification of NdeI and AatII flanked 5’CDPK1 
5UTR’_CpCPDK1 fragments with NdeI and AatII site at each end was amplified by 
using DNA isolated from freshly excysted sporozoites as template and forward primer 
5UTR’_CpCPDK1F and reverse primer 5UTR’_CpCPDK1R. The PCR program was 
set as 95 °C for 5 min; 35 cycles of 95 °C for 30 s, 47 °C for 30s, 72 °C for 91 s; 
72 °C for 5 min. 
3.2.3.2 Annealing of gRNA 
The forward primer was annealed with the reverse primer in a PCR tube with c 
polynucleotide kinase (PNK). Volumes of reagents used in the reaction are listed in 
Table 5.  
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Table 5. Composition of CpCDPK1 gRNA annealing. 
Reagents Volume (µl) 
Forward Primer (100μM) 1  
Reverse Primer (100μM) 1  
T4 ligase buffer (10X) 1  
PNK 0.5 
ddH2O 6.5  
Total  10  
 
The annealing program starts with a 30 min pre-warm step at 37 °C. Annealing: 1 
round at 95 °C for 5 min. The step was repeated 14 times, with the temperature 
decreasing by 5 °C in each round. Hold at 4°C overnight.  
 
3.2.3.3 Amplification of repair cassette via Touchdown PCR (TD-PCR) 
Involved reagents were used as listed in Table 6. TD-PCR was applied as follows: a) 
initial denaturation at 95 °C for 2 min; b) thermocycling: denaturation at 95 °C for 45 
s for each cycle; annealing temperature was gradually decreasing (1°C per cycle) from 
65 °C to 56 °C during the first 10 cycles, and remained at 55 °C in the following 25 
cycles with the consistent duration of 30 s; elongation at 72 °C for 112 s; c) final 
elongation at 72 °C for 10 min; hold at 4 °C. PCR products were visualized by gel 
electrophoresis and those with the length of 1836 bp were selected for sequencing  
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Table 6. Reagents and TD PCR program for the amplification of repair cassette. 
Reagents Volume 
(μl) 
Cycles  Temperature (°C) Time 
(s) 
ddH2O 18 1 95 120 
dNTPs 0.8 10 95 45 
Template (p71) 2.5 65 to 56(-1/cycle) 30 
Forward Primer (CDPK1koF) 0.5 72 112 
Reverse Primer (CDPK1koR) 0.5 25 95 45 
Taq Buffer 10X 2.5 55 30 
Taq polymerase 0.2 72 112 
Total 25 1 72 600 
 
3.2.3.4 Colony PCR 
Bacteria carrying plasmids were plated on LB agar and incubated overnight (see 
3.2.8). Colonies were picked and incubated in 500 µl LB medium at 37 °C for 2-3h. 
Colony PCR was performed to verify the success of the ligation and transformation. 
Reagents involved were listed below (Table 7). Program runs as follows: initial 
denaturation at 95 °C for 5 min; denaturation at 95 °C for 30 s, annealing at 53 °C for 
40 s, elongation at 72 °C for 1 min, repeat this cycle for 35 times; final elongation at 
72 °C for 1 min. Finally, 10 µl of each PCR products were loaded on agarose-gel for 
electrophoresis. Positive colonies were saved for further cultivation and plasmid 
extraction.   
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Table 7. Reagents of colony PCR. 
Reagents Volume(μl) 
Taq Buffer 10X 2.5 
dNTPs 0.8 
Primer T3 0.5 
Primer T7 0.5 
Taq polymerase 0.2 
Template (bacterium 
solution) 
2.5 
ddH2O 18 
 
3.2.3.5 Real-time PCR for C. parvum hsp70 
C. parvum heat shock protein 70 (hsp70) was selected as the reference gene. For each 
reaction 5 µl of template was used according to table 8 to quantify the hsp70 copy 
number in the template. DNA extracted from faeces was added into the 20 µl reaction 
system along with C. parvum hsp70 primers and Taqman probe. The qPCR program 
was designed as follows: denaturation: 95 °C for 15min; alignment: 40 cycles at 
95 °C for 15 s; elongation: 60 °C for 1 min. 
Table 8. Composition of qPCR reagents for Cp_hsp70 gene.  
Reagents Volume per reaction 
(µl) 
Template 5 
PCR Master Mix 2X 10 
ddH2O 3.88 
Cp_hsp 70 forward primer 0.24 
Cp_hsp 70 revers primer 0.72 
Cp_hsp 70 Taqman probe 0.16 
Total 20 
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3.2.4 Restriction enzyme digestion 
3.2.4.1 Restriction enzyme digestion of pA - pD 
Plasmids were cut by specific pairs of restriction enzymes at a temperature for 
catalysis of 37 °C and varying temperatures of 65 °C to 85 °C for inactivation. 
Duration of incubation was 10 to 60 min for catalysis and 5 min for inactivation 
(Table 8). The reaction system included 1 µg plasmid, 1 µl restriction enzyme and 2 
µl 10X FastDigest Buffer according to the manufacture’s instruction. Double distilled 
water (ddH2O) was added up to a total volume of 20 µl.  
 
Table 9. Temperatures and duration of incubation with restriction enzymes for 
catalysis and inactivation.  
Catalysis   Inactivation  
Name Temperature(°C)  Duration(min) Temperature(°C) Duration(min) 
AatII 37 20 85 5 
NdeI 37 60 65 5 
NheI 37 15 65 5 
MluI 37 15 80 5 
AvrII* 37 10   
*AvrII cannot be heat inactivated. 
 
3.2.4.2 Enzyme digestion and dephosphorylation of p185 
The plasmid Aldo Cas9 Ribo + U6 was digested by BbsI at 37 °C for 1 h or longer, 
until it was fully cut (<16 h). The reaction system included 1 µg plasmid, 1 µl 
restriction enzyme and 2 µl Cut Smart Buffer. Calf intestinal phosphatase (CIP, New 
England Biolabs® Inc, Ipswich) was used to dephosphorylate the plasmid at 37 °C for 
30 min (Table 10). Then the plasmid was purified again and diluted to 50 ng/µl.
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Table 10. Reagents used for Plasmid dephosphorylation. 
DNA 1 µg 
CutSmart® Buffer 
(10X) 
1 µl 
CIP 1 unit 
ddH2O Up to 20 µl 
 
3.2.5 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to separate DNA fragments. DNA samples were 
loaded in the wells of 1.5 % agarose gel. Electrophoresis was carried out under the 
voltage of 200 V for 30 min in 1 x TBE. GeneRuler 1kb DNA Ladder
®
 (Thermo 
Fisher Scientific, Waltham) or GeneRuler 100 bp DNA Ladder
® 
(Thermo Fisher 
Scientific, Waltham)
 
were used as reference. Afterwards, the gel was sunk in 0.01% 
EB solution for 30 min. The gel was imaged under UV light by ArgusX1 (Biostep, 
Burkhardtsdorf). 
3.2.6 Gel purification 
The target fragments were extracted from the gel by using GeneJET Gel Extraction 
Kit (Thermo Fisher Scientific, Waltham). After weighing the gel slice, 1:1 (buffer 
volume: gel weight) binding buffer was added into the tube and the tube was 
incubated at 50 – 60 °C for 10 min. Then up to 800 µl of gel solution was transferred 
into the GeneJET purification column along with 100 µl binding buffer and 
centrifuged at 12,000 rpm for 1 min in Mikro 200 (Hettich, Tuttlingen). Flow-through 
was discarded and 700 µl wash buffer was added to the column. Centrifugation at 
12,000 rpm for 1 min was applied and flow-through was again discarded. The dry 
columns were spun at 12,000 rpm centrifugation to remove residues on the membrane. 
DNA was eluted by centrifugation at 12,000 rpm for 1 min in 50 µl elution buffer 
supplied with the kit, then collected in 1.5ml Eppendorf tubes and stored at -20 °C 
until further use. 
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3.2.7 Ligation 
3.2.7.1 Ligation of CDPK1 KO plasmids 
By applying T4 ligation, different purified DNA fragments were inserted into the 
mutual pSC-A vector. For example, after 5’UTR_bAct is cut down from pA, it could 
be inserted in pB that is pre-cut by enzymes AatII and NdeI with T4 ligation. The 
other fragments could be also inserted into the same plasmid by performing the same 
method. 
T4 ligase kit was purchased from Thermo Fisher Scientific (Waltham). The reaction 
demanded 20-100 ng vector DNA, DNA fragment in an amount of 1-5 times of vector 
DNA, 2 µl buffer, 1 µl T4 ligase and nuclease-free water up to the total volume of 20 
µl. After being incubated at 22°C for 10 min, the ligation mixture was ready for 
transformation. 
3.2.7.2 Ligation of gRNA and p185 
T4 ligation was applied with different setups to optimize the dilution of insert with the 
highest of 1 and the lowest of 1/500 (Table 11). Controls were also included. Aim of 
treatment 1 was for controlling uncut plasmid and 2 for plasmid self-ligation. All 
setups were incubated at 4 °C overnight.
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Table 11. Reagents used in gRNA-plasmid ligation setups. 
Groups 
Reagents 
1 2 3 4 5 
Volume (μl) 
Cas9 Plasmid (50 ng) 1  1  1  1  1  
Annealed guides      1      
Annealed guides diluted 1:200       1    
Annealed guides diluted 1:500         1  
T4 DNA Ligase Buffer 1  1  1  1  1  
T4 DNA Ligase Enzyme   0.5  0.5  0.5  0.5  
Water 8  7.5  6.5  6.5  6.5  
Total Volume 10  10  10  10  10  
 
3.2.8 Transformation 
The XL1-Blue
® 
competent cells (Stratagene, San Diego) were stored at -80 °C. For 
transformation, 50 µl competent cells were thawed on ice. During the process, 0.9 µl of 
β-mercaptoethanol was added into the tube and was gently mixed every 2 min until the 
cell suspension was completely thawed. After 10 min incubation, 0.1-25 ng ligation 
products were added and the tube further incubated on ice for another 30 min. Then, the 
tube was heat-pulsed in a 42°C water bath for 45 seconds. Before mixed with 500 µl 
pre-heated super optimal broth with catabolite repression (SOC) medium, the tube was 
placed on iced and cooled down for 2 min. After 1 h shaking at 200 rpm at 37 °C, 20 µl 
of the bacteria suspension was spread on a lysogeny broth (LB) agar plate and 
incubated at 37 °C overnight.  
3.2.9 Plasmid extraction 
Bacteria was cultivated in 5 ml LB medium in a shaking incubator Incubator Hood 
TH 15 (Edmund Bühler, Bodelshausen) at 37 °C, 200 rpm overnight. After cultivation, 
the bacterium was collected in 1.5 ml Eppendorf tube and centrifuged at 8000 rpm for 
2 min. Discard the supernatant and refill the tube with bacterium. The step was 
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repeated until all cells were pelleted. The pellet was resuspended in the 250 µl 
Resuspension Solution by vortexing. Next, 250 µl Lysis Solution was added in the 
tube and the tube was inverted gently 4 - 6 times. 350 µl Neutralization Solution was 
added and mixed by immediately gentle inverting for 4-6 times. The mixture was 
centrifuged at 12,000 x g for 5 min to pellet the cell debris and chromosomal DNA. 
The supernatant was transferred to a Thermo Scientific GeneJET Spin Column and 
centrifuged at 12,000 x g for 1 min. 500 µl Wash Solution was added to the column 
and centrifuged at 12,000 x g for 1 min. The flow-through was discarded and the 
wash step was repeated once. Another centrifugation at 12,000 x g for 1 min followed 
to dry the column. GeneJET Spin Column was transferred into a 1.5 ml Eppendorf 
tube with 50 µl Elution Buffer at the center of its membrane. After 2 min incubation 
at RT, a centrifugation at 12,000 x g for 2 min was performed to elute the plasmid 
DNA. Plasmid was stored at - 20 °C. 
 
3.2.10 C. parvum oocysts excystation 
C. parvum oocysts were pelleted from PBS by centrifugation at 12,000 rpm for 4 min 
and then re-suspended in sodium hypochlorite (NaOCl). The oocysts were incubated 
on ice for 5 min and washed three times with cold PBS by centrifugation at 12,000 
rpm for 4 min. After washing, the oocysts were incubated in 0.8% sodium 
taurocholate (NaT)/infection medium at 15 °C for 10 min, then, incubated at 37 °C for 
1.5 h. Next, excysted sporozites were pelleted at 14,000 rpm for 8 min and filtered 
with ReliaPrep Filter 5 μm (Ahlstrom, Helsinki).  
 
3.2.11 C. parvum infection 
3.2.11.1 In vitro infection 
4×10
6 
excystated sporozoites were seeded into 24-well plates containing cells at the 
confluency at 70% - 80%. Throughout infection, growth medium was replaced by 
infection medium. 
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3.2.11.2 C. parvum infection in mice 
C. parvum oocysts were stored at 4 °C in PBS. Propagation and purification was 
performed 1 week before animal experimentation. A novel strain, RAGgc × 
IFN-gamma KO mice were purchased (Dr. Christoph Hölscher, Leibniz-Center for 
Medicine and Biosciences, Borstel). The mice were maintained in the animal facility 
of Max-Planck Institute for Evolutionary Anthropology, Leipzig. Twenty one 
6-week-old female RAGgc × IFN-gamma KO mice were randomly separated into 3 
groups. Groups 2 to 4 were orally gavaged with 500 oocysts, 1000 oocysts, or 5000 
oocysts of C. parvum per mouse, respectively. An additional six BALB/c WT mice 
were inoculated with 5000 oocysts as control group (G1). 
 
3.2.12 Transfection 
3.2.12.1 Electroporation for MDBK transfection 
The plasmid pCAG-mGFP-Actin (obtained from Addgene, Cambridge, USA) was 
used for MDBK cell transfection. Electroporation was performed with the ECM 830 
squarewave electroporator (BTX, Holliston). All electroporations were performed 
with incomplete cytomix buffer and complete cytomix buffer. Before electroporation, 
the cuvettes were washed with 70% ethanol and dried in the working bench. After 
MDBK cells were grown to 80% confluence they were detached by trypsinization and 
centrifuged at 1000 rpm for 10 min. The supernatant was discarded and the pellet was 
resuspended in incomplete cytomix buffer. Centrifugation was repeated once and the 
resulting cell pellet was resuspended in complete cytomix buffer. 5×10
6
 cells and a 
minimum of 55 µg BamHI linearized pCAG-mGFP-Actin plasmids were gently 
mixed in a cuvette. PBS was added up to a total volume of 500 µl. The cuvettes were 
electronically pulsed in the safety chamber. A range of voltages, pulse durations and 
interval lengths were tested to determine the optimal electroporation conditions. 
Before being seeded on the 24-well plate, cells were incubated at RT for 15 min in the 
working bench. Thereafter, the electroporated cells were incubated at 37°C, 5% CO2 
overnight. 
Animals, materials and methods 
37 
 
 
3.2.12.2 Electroporation for C. parvum transfection 
The mcherry reporter plasmid pCpact5’mcherryEtact3’(pmcherry), kindly provided 
by Anne-Kristin Teten (Institut für Zoologie, Technische Universität Dresden), was 
used for electroporation. Electroporation conditions were optimized for ECM 830 
square wave electroporator (BTX, Holliston) and Gene Pulser Xcell™ (Bio-rad, 
Hercules). For this purpose 5×10
6 
C. parvum oocysts or the same number of 
sporozoites were suspended in 500 µl incomplete cytomix buffer. The suspension was 
centrifuged at 200 x g for 5 min. The pellet was resuspened in a transfection cuvette 
in 800 µl complete cytomix buffer. 100 µg of plasmid was linearized before 
electroporation through incubation with 2 µl SapI (New England Biolabs
®
 Inc, 
Ipswich) at 37°C for 2 h and added to the suspension. The electroporation conditions 
varied in wave form, voltage and pulse duration. Dozens of combinations were 
applied to search the optimal conditions as shown in table 12.  
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Table 12. Range of eletroporation conditions for C.parvum transfection 
Parameters Voltage 
(V) 
Pulse duration 
(µs) 
Pulse 
times 
Wave Form 
Minimum 1000  100  1  Square wave (for 
oocysts and 
sporozoites) 
Maximum 3000 1000 10 Decay wave (for 
sporozoites only) 
 
3.2.12.3 CpCDPK1 knock out through Cell penetrating peptide (CPP) - 
octaarginine mediated transfection  
Plasmid p185 and the amplified repair cassette with CpCDPK1 flanks were incubated 
with CPP, specifically octaarginine, at the molar ratio of 1:400 at 37 °C for 1 h 
separately (Table 13). Then both compounds were mixed with freshly excysted 
sporozoites and incubated at 37 °C for another 1 h. At last, the sporozoites were 
seeded to COLO - 680 N or HCT - 8 cells at the confluency of 80%. Infected cells 
were cultivated at 37 °C for 2 weeks in growth medium DMEM with paromomycin (6 
mg/ml). Medium was changed once a week. Passage was performed every 2 weeks.  
Table 13.  Reagents used for CPP-DNA compound. 
 p185 Repair cassette 
Reagents Volume (μl) Volume (μl) 
DNA 5 μg (volume varies to 
concentration of DNA) 
5 μg (volume varies to 
concentration of DNA) 
Octaarginine 2.5 13.7 
Polyethylenimine 
(PEI) 
2.5 2.5 
Growth medium 
DMEM 
up to 1000 up to 1000 
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3.2.13 Geneticin screening for GFP-MDBK cells 
Fluorescent microscopy (DM IRB, Leica, Wetzlar) was applied every 24 h after 
electroporation to check the transfection efficiency. Filter FITC was selected to detect 
the GFP signal. MDBK cells which expressed GFP were picked under the 40× 
objective lens and seeded into new plates for growth of transfected cells. 
Fluorescence-activated cell sorting (FACS) was applied when monolayers reached 
confluence of 80%. FACS Aria™ III (Becton Dickinson, Heidelberg) was used for 
the cell sorting. Single cells strained through a 40 µm mesh were analyzed by the 
software FACSDiva™ V6.5 (Becton Dickinson, San Jose). The GFP signal was 
excited by the 488 nm laser and detected with the 530/30 Filter. The pulse geometry 
gates that measure the forward and side scatter light signals in area (FSC-A/SSC-A) 
were used for gating cells, doublets of cells in the flow were eliminated by FSC-A, 
FSC-H (forward scatter light signal in height). At last the GFP expression was 
analyzed (GFP/FSC-A). Low and high expressing cells were gated and the cells in 
these gates were physically sorted into tubes containing DMEM medium pre-cooled 
to 4 °C. Sorted cells with intense signal were seeded back on the culture plate and 
incubated in complete DMEM at 37 °C. 
After 24 h of incubation the aminoglycoside antibiotic G418 (500 µg/ml, Thermo 
Fisher Scientific, Waltham) was introduced into cultures of transfected MDBK cells. 
Cultures were checked daily under fluorescent microscope (40×/0.5, FITC). Growth 
medium and G418 were replaced every 72 h over the culturing period of 2 weeks. 
Cells that continuously displayed the green fluorescent signal were harvested and 
stored in liquid nitrogen until further use.   
 
3.2.14 Indirect immunofluorescent assay (IFA) 
The IFA was performed to visualize C. parvum. Infected monolayers were fixed in 
fixation solution for 20 min at RT. The slide was incubated in permeabilization 
solution for 20 min at RT to increase permeability of cell membranes. Thereafter 
blocking buffer was applied for 1 h. Primary and secondary antibodies were applied to 
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the monolayer stepwise for 1 h at RT. Specific antibodies and dilutions in blocking 
buffer used for different experiments are listed in Table 14. 
4',6-diamidino-2-phenylindole (DAPI) solution with the concentration of 0.1 µg/ml  
was  added for a 4 min staining at RT. Monolayers were washed 3 times with 0.2 % 
Triton/PBS between each step. The specimens were mounted on glass slides with the 
help of Fluoromount-G
TM 
(Thermo Fisher Scientific, Waltham). 
Table 14. Antibodies and their dilutions used in IFA 
 Primary antibody Secondary antibody 
WT infection Rat anti-Crypto (1:3000) Dylight
TM
 647 anti rat 
IgG 
Infection after C. 
parvum transfection 
Rat anti-Crypto (1:3000) Dylight
TM
 488 anti rat 
IgG (H&L) (1:3000) 
Mouse anti-human 
neomycin 
phosphotransferase 
(1:1000) 
Alex Fluor
TM
 647 
anti-mouse IgG (1:1000) 
 
Confocal laser scanning microscopy (CLSM) was applied by TCS SP8 system (Leica, 
Wetzlar) to detect fluorescent signals and to capture images. The object lens for all 
fluorescent signals was a glycerol lens with 63 times of magnification and 1.3 of 
numerical aperture. Argon laser was applied consistently at the intensity of 20 %. The 
photo-multiplier tube (PMT) was used as detector for DAPI and green fluorescent 
signals and HyD for the red fluorescent signals.  
3.2.15 Animal feeding and body conditioning score (BCS) monitoring 
The mice were observed and weighed every day over the investigational period. Body 
condition was recorded daily considering weight, fur, posture, body temperature and 
responsiveness towards external stimulation. The body condition scores were rated 
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according to table 15. Mice scored ‘4’ were regarded intolerably suffering and were 
humanely sacrificed. Drinking water with metamizol (250mg/100ml) was replaced 
every day and accessible ad libitum. Glucose (20%) was added to drinking water to 
stimulate water consumption. The dose of metamizol was increased to 500 mg/100 ml 
when at least one mouse in a group was rated ‘3’. 
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Table 15.  Body conditioning score of mice. 
Scoring Body conditions 
4 
>>> euthanasia 
 
  
emaciated 
- bones are generally not or hardly covered by visible 
musculature 
- the back vertebrae are clearly discernible 
- 20 % or more weight loss 
- apathia 
- no or almost no reaction to touch 
- body temperature below 34 °C 
- inability to rise 
- strong gastrointestinal cramps (buckling, recognizable 
bowel movement) 
3 
  
underweight 
- segmentation of the vertebral column visible 
- pelvic bones easily palpable 
- weight loss of about 10 % 
- the mouse separates from mates , eats less, humps its 
back 
2 shaggy coat 
1 normal weight 
- spine and pelvic bones covered by muscle, barely visible 
and difficult to palpate 
- smooth fur 
- normal behavior 
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3.2.16 Faecal sample collection 
Feces were collected daily from day 0 to day 4 p.i. and then every second day until 
day 21 p.i.. Mice were kept group wise in cages, however, for feces collection 
individuals were separated over 2 h following weighing. Faeces samples were stored 
in 1.5 ml plastic tubes at -20 °C until further use. 
 
3.2.17 DNA extraction and oocysts per gram (OPG) determination of fecal 
samples 
DNA was extracted from 100 mg of feces collected from each mouse through 
NucleoSpin
®
 DNA Stool Kit (Macherey-Nagel GmbH & Co.KG, Düren) according to 
the manufacturers’ protocol. Feces were mixed with 1 ml ST1 lysis buffer in 
NucleoSpin® Bead Tubes which were pre-filled with ceramic beads. Then the feces 
underwent ultra-sonication for 8 min (Amplitude: 60 %, Puls: 0.5 ms, Bandelin 
sonopuls GM70, Berlin). After extraction, DNA was eluted in 50 µl molecular grade 
water and stored at -20 °C.  
Real-time PCR was performed to detect the Cp_hsp 70 gene copies in the faecal 
samples. As 5 µl of the total volume of 50 µl of DNA extracted from 100 mg of 
faeces were used as template for qPCR, and 1 oocyst contains 4 sporozoites = 4 
genomes, the numbers of oocysts per gram (OPG) of faeces were calculated from the 
number of Cp_hsp 70 gene copies according to the following formula: 
 
𝐎𝐏𝐆 = 𝐧 ×
𝟓𝟎
𝟓
÷ 𝟒 ×
𝟏𝟎𝟎𝟎
𝟏𝟎𝟎
= 𝟐𝟓 × 𝐧 
 
n= Cp_hsp70 gene copies 
50/5: ratio total DNA volume/volume used as template 
4: number of genomes per oocyst 
1000/100: ratio one gram of feces to weight of taken feces 
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3.2.18 Statistical analysis 
SPSS 22.0 (IBM, New York, USA) was used for statistical analysis. One sample 
Kolmogorov-Smirnov test was performed to test for normal distribution of data. Since 
data did not follow a normal distribution, nonparametric tests, Wilcoxon signed-rank 
test (for paired samples) and Mann-Whitney U test (for independent samples) were 
performed to evaluate whether intra- and inter-group data differed significantly at P < 
0.05.  
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4. Results 
4.1 CDPK1 knockout by REMI 
At first, the attempt was made to generate mutation in C. parvum by REMI. In 
principle, the presence of restriction enzyme leads to random cleavages in 
sporozoites’s genome and the linearization of plasmid. After the translocation of the 
plasmid by electroporation, the compatible cohesive ends in both the parasite’s 
genome and linearized plasmids can ligate. This allows the integration of the plasmid 
into the genome through homologue recombination, and thereby the CDPK1 KO 
mutants can be generated and survive in the following drug screening.  
4.1.1 Construction of Knockout plasmid 
 
To construct CDPK1 knockout plasmid, the plasmids pA - pD were specifically 
cleaved by restriction enzymes. The cut-down fragments were inserted into the same 
plasmid stepwise as shown in Fig. 4. 
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Figure 4. Schematic presentation of construction of CpCDPK1 gene knockout 
plasmid. Target fragments were cut from the stored plasmids (pA-pD) and 
inserted into another plasmid through T4 ligation and transformation. Different 
fragments were inserted sequentially to achieve the knockout plasmid. In this 
example nptII with restriction enzyme overhang was nicked and pSC-A-YFP 
plasmid was cut with the same double restriction enzyme. Through T4 ligation 
and XL1-blue transformation, the pSC-A-nptII-YFP was constructed. Following 
this procedure fragments such as 5’CDPK1, 5’bAct or 3’CDPK1 were also 
inserted to obtain the final plasmid.  
 
A plasmid (pSC-A-5’UTR_bAct-nptII-YFP-3’CpCDPK1) with 4 external inserts and 
pSC-A backbone was generated. Each insert was verified by enzyme digestion and 
analyzed on agarose gel. The plasmid showed positive bands on gel after cleavage by 
restriction enzymes (Fig. 5). The sizes of various fragments were as follows, 
5’UTR_bActin: 924 bp; nptII: 796 bp; YFP: 822 bp; 3’UTR_CDPK1: 1491 bp. The 
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sequencing results confirmed the correctness of the construct with identities of 100% 
of all fragments. 
 
Figure 5. Plasmid pSC-A-5’UTR_bAct-nptII-YFP-3’CpCDPK1 analyzed by 
enzyme digestion and gel electrophoresis. Agarose concentration: 1.5%. Lane 1-4 
represent the products of cutting by different pairs of restriction enzymes. 1: 
NdeI and AatII; 2:AatII and NheI; 3: NheI and AvrII; 4: AvrII and MluI. Lane M 
is for marker. 
 
The 5’UTR_CpCDPK1 was amplified and used to replace the 5’ UTR_bAct (Fig. 6). 
Finally, plasmid pSC-A-5’UTR_CpCDPK1-nptII-YFP-3’UTR_CpCDPK1 was 
constructed. With the generated construct bearing identical 5’ and 3’ regions with the 
CpCDPK1 gene locus, homologous recombination could now be performed in order 
to replace the original gene with the construct. This was achieved by transfecting the 
generated construct into the parasite. The successful integration of the construct will 
silence CpCDPK1 and enable the expression of the nptII-YFP reporter. 
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Figure 6. Plasmid pSC-A-5’UTR_CpCDPK1-nptII-YFP-3’UTR_CpCDPK1 
analyzed by enzyme digestion and gel electrophoresis. Agarose concentration: 
1.5%. Lane 1-4 represent the products of cutting by different pairs of restriction 
enzymes. 1: NdeI and AatII; 2: AatII and NheI; 3: NheI and AvrII; 4: AvrII and 
MluI. Lane M is for marker and C for uncut plasmid as control. 
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4.1.2 Electroporation protocol and in vitro analysis 
In order to determine the optimal condition for electroporation, the reporter plasmid 
pCpact5’mcherryEtact3’ was used. Transfection was found effective with the voltage 
range of 2500 - 3000 v and the pulse duration of 0.8 - 1 ms by Gene Pulser Xcell™ 
(Bio-rad, Hercules) (Fig. 7). Positively transfected parasites at intracellular stages 
were detected in MDBK cell culture after 48 h p.i. by IFA. However, when using 
ECM 830 square wave electroporator (BTX, Holliston), no transfected parasites were 
detected. 
 
 
Figure 7. IFA of C. parvum electroporated with actin-mCherry plasmid 
pCpact5’mcherryEtact3’ obtained with the decay wave electroporater Gene 
Pulser Xcell™. Scale bar length: 5 μm. 
 
In order to knockout the CDPK1 gene, the reporter plasmid pCpact5’mcherryEtact3’ 
was replaced by plasmid pSC-A-5’UTR_CpCDPK1-nptII-YFP-3’UTR_CpCDPK1 
and the restriction enzyme Sap I was replaced by Nde I to linearize the plasmid in the 
subsequent electroporation. After incubation for 48 h post-infection, the culture was 
stained by DAPI and Sporo-glo. Untransfected C. parvum were detected meanwhile 
no transfected parasites could be spotted for any electroporation setup (Fig. 8).  
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Figure 8. IFA of electroporation of C. parvum sporozoites with plasmid 
pSC-A-5’UTR_CpCDPK1-nptII-YFP-3’UTR_CpCDPK1. Scale bar length: 5 
μm. 
 
Because the use of REMI for the generation of CDPK1 K/O parasite line was 
unsuccessful I wondered whether this might be due to the method or reflect that 
CDPK1 gene was essential, making it impossible to generate a transgenic K/O line. I 
decided to attempt the knockout of CDPK1 using the more efficient and recently 
introduced CRISPR/Cas 9 technology (VINAYAK et al. 2015; PAWLOWIC et al. 
2017).  
 
4.2 CDPK1 knockout by CRISPR/Cas 9-mediated gene editing 
In the CRISPR/Cas 9 based approach to silence CpCDPK1 the strategy starts with the 
cleavage of the CpCDPK1 gene in the C. parvum’s genome with the gRNA-oriented 
nuclease cas 9 to generate a double strand break (DSB). When DSB occurs, C. 
parvum will activate a repairing pathway to fix the DNA lesion, through homology 
directed repair (HDR). A cassette bearing sequences homologous to both ends of the 
CpCDPK1 gene was introduced into the cell through transfection to repair the DSB 
thereby disrupting the target gene and introducing a reporter that consists of a Nano 
luciferase gene and neomycin phosphotransferase gene (nptII). As nptII gene confers 
kanamycin, neomycin, geneticin, and paromomycin resistance to cells, successfully 
transfected parasites were selected by paromomycin (Fig. 9).  
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Figure 9. Genetic strategy to knock out CpCDPK1 using CRIPR/cas9 approach 
and the primers designing for repair cassette amplification. (a). Repair cassette 
containing enolase promoter (EnoP), nanoluciferase gene (Nluc) and neomycin 
resistance gene (NeoR) and supplemented at both ends with 50bp flanks (black) 
which are identical to the 5’UTR and 3’UTR of CpCDPK1. It was aimed to 
replace the CDPK1 open reading frame (CpCDPK1 ORF, red). (b) To amplify 
the repair cassette, the primers were designed with 22 bp long heads (arrowed 
bars) for the repair cassette and containing the 50 bp flanks (black). 
 
4.2.1 Constructing CRISPR/Cas9_CpCDPK1_7 plasmid 
A gRNA associated with CRISPR/cas 9 plasmid is essential in order to guide the 
enzyme function at the target gene locus. The gRNAs were designed using the online 
program EuPaGDT (http://grna.ctegd.uga.edu/). Out of 50 suggestions, 2 gRNAs 
(CpCDPK1_7 and CpCDPK1_181) with the length of 20 bp were selected for their 
high scores evaluated by the program based on multiple factors such as on-target 
efficiency, off-target rate, “GC” contents and so on. A manual “G” was added to the 5’ 
end of the guides when it did not start with “G” for an appropriate transcription by the 
U6 promoter. Thus, two pairs of short oligonucleotides were designed. More 
specifically, they are forward primers with the same sequence of the guide and a 
reversed complement (Table 4). To the 5’ end, an additional “GTTG” was added 
artificially to the forward primer and “AAAC” to the reverse primer to offer the 
gRNA compatibility to restriction enzyme site BbsI which exists also in the plasmid. 
After annealing PCR, gRNAs were generated carrying BbsI sticky overhangs at both 
ends. 
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In order to gain maximal HDR efficiency, the CpCDPK1_7 was used in further 
cloning because its targeting site on CDPK1 gene locates nearer to the start codon. 
Annealed gRNA (CpCDPK1_7) was inserted into plasmid p185 after restriction 
enzyme digestion and ligation. Colony PCR was applied with the gRNA screening 
primer and CpCDPK1_7 R. Since the binding loci of these two primers are 207 bp 
apart, bands on gel with the approximate size of 200 bp were considered positive and 
harvested for sequencing. The sequencing result confirmed that gRNA CpCDPK1_7 
was inserted at the correct locus. Thus, plasmid CRISPR/cas 9 - CpCDPK1_7 was 
constructed (Fig. 10). This plasmid was ready to use in the subsequent transfection to 
disrupt the CpCDPK1 gene in the C. parvum genome.  
 
 
Figure 10. Schematic construction of plasmid CRIPSR/cas 9 – CpCDPK1_7. The 
restriction enzyme site BbsI was replaced by gRNA: CpCDPK1_7 through 
cloning.  
4.2.2 Amplification of CDPK1 flanked repair cassette 
The next step was to prepare the template for HDR which is the CDPK1 flanked 
repair cassette (Fig. 9). By TD PCR, the 1788 bp long repair cassette bearing 
5’UTR_CDPK1, nanoluciferase, nptII and 3’UTR_CDPK1 was amplified and 
assessed by agarose gel electrophoresis (Fig. 11). Fragments were isolated from gel 
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and purified using GeneJET Gel Extraction Kit (Thermo Fisher Scientific, Waltham). 
The PCR product was verified by sequencing delivering identities of 100%. The 
repair cassette was then readily prepared in the flowing transfection step as an 
external repairing template to replace the endogenic CpCDPK1.  
 
Figure 11. Gel electrophoresis of TD PCR products. 1: lane loaded with 5 μl of 
TD PCR products. M: lane loaded with GenerulerTM 1kb DNA Ladder 
(Thermo fischer, Waltham) as marker. 
4.2.3 Knockout CDPK1 via CRISPR/cas 9 
To understand the function of CpCDPK1, I tried to knockout this gene from the 
genome of C. parvum through two transfection methods, electroporation and CPP 
transfection. 
4.2.3.1 Electroporation and in vitro analysis 
Electroporation was performed using CRISPR/Cas9_CpCDPK1_7 plasmid and 
CDPK1 flanked repair cassette. The parameters of electroporation were applied 
almost the same as described previously (see 3.2.12.2) except the addition of 
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restriction enzyme. Transfected sporozoites were cultivated with HCT-8 cells and 
COLO-680 N cells for 24 h in presence of paromomycin. Through IFA, positive 
transfections including intracellular and extracellular parasites were detected in both 
cell lines (Fig. 12 and 13).  
 
 
Figure 12. IFA of CpCDPK1 knockout C. parvum in HCT-8 cells by CRISPR/cas 
9 and electroporation. Free sporozoites (a) and intra-cellular stages (b) were 
revealed. Sporo-glo was used for the detection of C. parvum and anti-nptII (Alex 
FluorTM 647) for the expression of nptII. Scale bar length: 5 μm. 
 
Figure 13. IFA of CpCDPK1 knockout C. parvum in COLO-680 N cells by 
CRISPR/cas 9 and electroporation. Free sporozoites (a) and intracellular stages 
(b) were revealed. Sporo-glo was used for the detection of C. parvum and 
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anti-nptII (Alex FluorTM 647) for the expression of nptII. Scale bar length: 5 
μm. 
 
4.2.3.2 CPP transfection and in vitro analysis  
Due to the drawbacks of electroporation e.g. massive demands of DNA and 
unnecessary cell damage caused by electric pulses, cell-penetrating peptide (CPP) 
assisted-transfection served as an alternative without these disadvantages. CPPs are 
short positively charged peptides that were shown to be able to carry a wide range of 
cargoes including drugs, nucleic acids and proteins across nearly all known biological 
membranes (DERAKHSHANKHAH and JAFARI. 2018). The CPP applied in the 
present study was octaarginine. Like other CPPs, it is able to function as vector for 
intracellular delivery with limitied cytotoxicity and has been successfully applied in 
Plasmodium (SPARR et al. 2013).  
CPP transfection was performed by using freshly excysted sporozoites and CPP 
complexed DNA as described in previous chapter (see 3.2.12.3). IFA results revealed 
that the transfection was successful (Fig. 14a), as well as in the electroporation control 
(Fig 13). The CPP transfected sporozoites were seeded into HCT-8 cells and 
incubated for 24 h prior to IFA. Positive transfection was detected (Fig. 15). 
Since the COLO – 680 N cells were reported suitable to maintain C .parvum for long 
term and to allow the parasite to complete its lifecycle in vitro, the cells infected with 
transfected C. parvum were regarded as the 1
st
 generation of culture. Then, passage 
was applied every two weeks. IFA was performed for the 2
nd,
 3
rd,
 5
th
 and 6
th
 
generation. Finally, immunostaining revealed that anti-nptII-positive parasites could 
be observed until generation 6 (Fig. 14b - e). These findings suggest that the 
transfection succeeded due to external paromomycin resistant gene was maintained 
over passages.  
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Figure 14. IFA of transfected C. parvum in COLO – 680 N cells by CPP 
transfection: generation 1 (a), 2 (b), 3 (c), 5 (d) and 6 (e). Anti-crypto (DylightTM 
488) was used for the detection of C. parvum and anti-nptII (Alex FluorTM 647) 
for the expression of nptII. Scale bar length: 5 μm. 
 
 
Figure 15. IFA of transfected C. parvum in HCT-8 cells by CRISPR/cas 9 and 
CPP transfection. Sporo-glo was used for the detection of C. parvum and 
anti-nptII (Alex FluorTM 647) for the expression of nptII. Scale bar length: 5 
μm. 
 
Despite the parasites could be detected after several passages, the population 
maintained at an extremely low level without any obvious change throughout the 
study. 
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4.2.3.3 Genetic assay of transfection 
The transfection was also analyzed molecularly. HCT-8 cells were infected with 2 × 
10
5
 freshly excysted sporozoites of C. parvum. The culture medium was 
supplemented with 6 mg/ml paromomycin. The DNA was extracted from infected 
cells at various time points post-infection. Quantitative PCR revealed that transfected 
groups possessed nearly 4 fold more C. parvum DNA copies than the control infected 
with non-transfected parasites 24 h after infection. Moreover, the DNA copies of C. 
parvum in the transfection group kept increasing until day 3 and dropped slightly 2 
days later (Fig. 16).  
 
Figure 16. DNA copies of transfected C. parvum quantified by real time PCR at 
different time points after infection of HCT-8 cells. NI: non-infected cells; WT: 
Wild type (non-transfected) C. parvum (1d p.i.). 
 
Conventional PCR was also performed to check the CDPK1 knockout. Several pairs 
of forward primers which bind with the 5’UTR of CDPK1 and the reverse primers 
bind with the Nluc-nptII repair cassette were designed. Attempts to amplify a 
fragment which overlaps the conjunction locus (genomic CDPK1 – repair cassette) 
with these primers and DNA extracted from cell cultures were made. However, no 
positive bands with expected size were detected on the agarose gel by electrophoresis. 
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4.3 In vitro and in vivo model for infection and propagation 
Until now it has not been possible to develop an in vitro culture that enables a sexual 
reproduction of the parasite to generate large numbers of sporulated oocysts. So far, 
the only viable protocol to maintain transfected C. parvum requires the injection of 
freshly transfected sporozoites directly into the small intestine of a mouse. This is a 
very cumbersome and invasive procedure. Due to this problem the generation of 
transgenic parasites in order to study gene function remains a very challenging task. 
For propagation of genetically modified organismns such as CDPK1 knockout C. 
parvum in vitro methods would be clearly preferable due to biosecurity and animal 
welfare issues. Thus I attempted to establish the COLO - 680 N cell line according to  
(MILLER et al. 2017) hoping that this might allow massive production of freshly 
sporulated (transfected) oocysts without using animal models. 
 
4.3.1 In vitro model - C. parvum cultivation in COLO - 680 N cells 
COLO - 680 N cell line was reported capable of effective propagation of C. parvum in 
vitro. Therefore, I infected the cells with C. parvum sporoziotes at the confluency of 
70% - 80%. Parasites at intracellular stages were detected in the culture by IFA 
suggesting that the cell line is susceptible for C. parvum infection (Fig. 17).  
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Figure 17. Intracellular stages of wild type C. parvum in COLO - 680 N cells. 
DAPI was used to stain the chromosome and anti-crypto (DylightTM 488) was 
used for the detection of C. parvum. Scale bar length: 5 μm. 
 
The infected cells in 5 x T25 flasks were maintained for 8 weeks and the medium was 
changed once per week. Supernatant of all flasks were combined, however only 1 
oocyst was observed. The harvested oocyst was stained by Crypto-a-glo (Waterbone, 
New Orleans) (Fig. 18). Moreover, no further oocysts were found in the other three 
repetitions. The poor efficiency and repeatability suggested the idea of continuous 
propagation of C. parvum in COLO – 680 N cell line was unrealistic.  
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Figure 18. Oocyst harvested from supernatant of C. parvum infected COLO - 680 
N cells. White arrow points at the oocyst. Magnification: 20 × 10. 
 
4.3.2 In vivo model Infection pattern of C. parvum in RAGgc x IFN-g KO mice 
As the COLO – 680 N cells could not serve as an in vitro model for the propagation 
of C. parvum, a trial in the RAGgc x IFN-g KO mouse was performed to evaluate its 
suitability for infection and propagation of C. parvum. Data of body weight, BSC and 
oocysts shedding were collected. 
4.3.2.1 Clinical symptoms 
As previously described in 3.2.11.2 and 3.2.14, experimental mice were orally 
infected with different doses of C. parvum oocysts and maintained until SD 21. Daily 
observation was performed to monitor the body weight and BCS. 
Two mice in G2 displayed severe clinical symptoms of disease such as emaciation, 
rough fur and trembling. These mice died on SD 15 and SD 16, respectively. After SD 
20, one mouse in G3 and three mice in G4 were found dead in the cage. Throughout 
the study, the survival percentage was 71.4 % (G2), 85.7 % (G3), 57.1 % (G4) and 
100 % (G1) (Fig. 19).  
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Figure 19. Survival percentage of crossbred KO mice (G2, G3, G4) and Balb/c 
(G1) orally infected with 500 (G2), 1000 (G3), or 5000 (G1, G4) oocysts of C. 
parvum.  
 
Diminished responsiveness towards external stimulation was only observed in 
moribund mice within 24 h before death. Abnormal fur roughness was firstly recorded 
in three mice of G4 on SD 6, followed by three mice of G2 and four mice of G3 on 
SD 10. Until the termination of the experiment, abnormal fur roughness became 
successively obvious in all animals of the three groups of KO mice (G2, G3, and G4), 
whereas this was not seen in any of the infected BALB/c mice of G1.  
The body weight of mice of G3 and G4 remained unaffected (P ≥ 0.05) until SD 9, 
and for G2 until SD 10 (P ≥ 0.05). Thereafter, rapid emaciation was observed in all 
KO groups (G2, G3, and G4). The decrease in body weight became statistically 
significant on SD 10 (P < 0.05) in groups G3 and G4 and on SD 11 in group G2 (P < 
0.05). In groups G2 and G4, body weights appeared to increase again, at least 
temporarily, after SD 14 (G2) or SD 19 (G4). No such recovery was seen in group G3. 
In contrast, immunocompetent BALB/c mice (G1) did not experience any relevant 
Results 
62 
 
growth retardation and displayed a continuous increase in average body weight over 
the study period with only temporary fall-backs on SD 4 and SD 7. Moreover, the 
weight became significantly higher than the initial value first on SD 3 and thereafter 
from SD 5 onwards (Fig 20). 
 
Figure 20. Mean body weights of crossbred KO mice (G2, G3, G4) and Balb/c 
mice (G1) following infection with 500 (G2), 1000 (G3), or 5000 (G1, G4) oocysts 
of C. parvum.* presents for the study day when statistical significance in body 
weight firstly showed.  
 
Body temperature of G1 mice oscillated between 37.3 °C and 38.5 °C, and no overall 
increase or decrease was observed. In contrast, body temperature tended to decrease 
in crossbred KO mice of groups G2, G3, and G4 and this trend became particularly 
obvious in comparison to G1 from SD 11 onwards. However, no statistically 
significant group difference was observed on any day over the study period (Fig. 21). 
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Figure 21. Average body temperature of crossbred KO mice (G2, G3, G4) and 
Balb/c mice (G1) over the study period (SD = study day) following infection with 
500 (G2), 1000 (G3), or 5000 (G1, G4) oocysts of C. parvum on SD 0 
 
4.3.2.2 Oocysts excretion  
The oocysts excretion was investigated by qPCR and OPG was calculated as 
described in 3.2.16. In order to evaluate whether Cp_hsp 70 copy numbers obtained 
by qPCR can suitably reflect OPG, 10
2
 - 10
7
 of oocysts were used to spike mouse 
faeces and estimated by the same method. Mean OPG numbers calculated on this 
basis were above 90 % of expected values except for the samples spiked with 10
5
 
oocysts per 100 mg where detection efficacy was somewhat lower with 87.5% (Table 
16). Regression analysis confirmed that calculated OPG numbers closely correlated to 
the expected OPG with R
2
 = 99.83% (Fig. 22). Altogether, OPG determination from 
DNA copies appeared reasonably suited to assess excretion patterns of C. parvum 
infected mice. 
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Table 16. Evaluation of efficacy of quantification of oocysts in faecal samples by 
qPCR 
Spiked OPG Detected DNA copies Calculated OPG (Mean) Efficacy 
1.00E+03 4.49E+01 1.12E+03 112.33% 
1.00E+04 3.67E+02 9.18E+03 91.75% 
1.00E+05 3.50E+03 8.75E+04 87.50% 
1.00E+06 4.25E+04 1.06E+06 106.25% 
1.00E+07 3.68E+05 9.20E+06 92.00% 
1.00E+08 3.98E+06 9.95E+07 99.50% 
100 mg faeces were spiked with C. parvum oocysts in a range of 10
2
 - 10
7
. Thus, 
spiked OPG ranged from 10
3
 -10
8
. DNA was extracted from the spiked samples 
and qPCR targeting Cp_hsp70 was performed. OPG were calculated from DNA 
copies of the Cp_hsp70 gene (formula: see 3.2.17); Efficacy = Calculated OPG 
÷ Spiked OPG × 100%. 
 
Results 
65 
 
 
Figure 22. Correlation between OPG calculated from qPCR data and numbers 
of oocysts used to spike faecal samples. Power regression was applied to analyse 
the goodness-of-fit between Caculated OPG Spiked OPG, R2 indicates the 
coefficient of determination (X axis :logarithmic scale). 
 
KO mice inoculated with 5000 C. parvum oocysts per mouse (G4) delivered positive 
PCR signals as early as SD 1 whereas those infected with 1000 (G3) or 500 (G2) 
oocysts became positive at SD 2 at the earliest (Fig. 23). OPG increased in all groups 
of KO mice (G2, G3, G4) rapidly and significantly compared to the amount during the 
first day of oocyst excretion (P < 0.05) and peak excretion was recorded on SD 10 
(G2, G4) or SD 12 (G3). Oocyst shedding remained at a high level of >10
8
 OPG 
afterwards with little variation. The three groups of KO mice (G2, G3, G4) did not 
differ remarkably in OPG over the whole experimental period and particularly after 
peak excretion (P > 0.05). 
In the control group (G1), oocysts were detected in faecal samples at the earliest on 
SD 2. OPG increased slightly but steadily over the study period, however, values 
remained significantly lower than in the KO groups (G2, G3, G4; P < 0.05) from SD 6 
onwards and always remained lower than 10
5
 OPG. 
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Figure 23. Average OPG of calculated from faeces based on qPCR data. 
Immunocompetent (BALB/c, G1) or immunodeficient KO mice (G2, G3, G4) 
infected with a dose of 500 (G2), 1000 (G3) or 5000 (G1, G4) oocysts of C. parvum 
at study day (SD) 0 (y axis: logarithmic scale). * 
 
4.4 In vitro inhibition of CDPK1 
As the generation of CpCDPK1 KO strain faced unforeseen difficulties, the functional 
study was reoriented from using genetic modification to chemical inhibition.  
To understand the role that CDPK1 gene plays in the invasion processes, I decided to 
investigate its influence on host actin remodeling. MDBK cells were applied because 
these cells assemble as monolayer in culture in a way that makes them superior to 
HCT-8 cells when being observed by microscopy. First, MDBK cells were transfected 
with plasmid pCAG-mGFP-Actin by electroporation as described in 3.2.12.1. Then, 
the cells were infected by C.parvum treated or non-treated with CDPK1 inhibitor. The 
host cell actin remodeling was analyzed by immunofluorescent microscopy.  
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4.4.1 Generating bAct-GFP-MDBK cells 
The optimal electroporation conditions for MDBK cells were determined. At least 55 
μg pCAG-mGFP-Actin plasmid were applied to 5 × 106 suspended MDBK cells in 
the complete cytomix buffer with the total volume of 500 μl. Five pulses were applied 
by ECM 830 square wave electroporator (BTX, Holliston), with the voltage of 900 V 
and the duration of 990 μs. Efficiency of transfection reached approximately 20%, 
which turned out to be the highest among all trials. The MDBK cells started to 
express GFP 24 h post electroporation (Fig. 24a). However, the percentage of GFP 
positive MDBK cells decreased during cultivation due to the overgrowth by 
untransfected cells. Therefore, the transfected cells were isolated with a micropipette 
and seeded into a new petri dish. Geneticin (G418) was added as selection drug with 
the working concentration of 250 μg/ml. After 10 days cultivation, the percentage of 
GFP-MDBK cells gradually achieved 100% (Fig. 24b and 24c). Once the cells 
reached confluency, they were trypsinized and sorted by FACS according to 
fluorescent intensity. Cells that strongly expressed GFP were seeded in a separate 
petri dish and confocal fluorescent microscopy was applied. Beta-actin filaments 
could be clearly observed (Figure 25).  
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Figure 24. Transfected bAct-GFP-MDBK cells. All images were taken with the 
magnification of 400 times. BF: Bright field. GFP: Fluorescence microscope with 
FITC filter to detect GFP expression. a: 24 h after electroporation; b: 24 h after 
passage; c: 10 days after passage. Magnification: 10 × 40. 
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Figure 25. CLSM of bAct-GFP-MDBK cells at 24 h after sorting through FACS. 
GFP expressed in the actin filaments was detected by photomultiplier (PMT) 
detector. Scale bar length: 20 μm. 
 
Next, the purified bAct-GFP-MDBK cells were harvested and stored in 2 ml 
Cryo-vials tube (Carl Roth, Karsruhe) containing 50% DMSO-growth medium in 
liquid nitrogen. After 4 weeks, the cells were recovered from cryopreservation and 
cultivated in growth medium for 10 days. The cells were confirmed to be able to 
express GFP after cryopreservation and recovery for at least 4 weeks (Fig. 26).  
 
Figure 26. The bAct-GFP-MDBK cells recoverd after cryopreservation. 
Confluence of 100% was achieved after 10 d. BF: bright filed. GFP: 
Fluorescence microscope with FITC filter to detect GFP expression. 
Magnification: 10 × 10. 
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4.4.2 Influence of CDPK1 inhibition on infection  
The bumped kinase inhibitor of CDPK1, compound 1294, was added to growth 
medium of MDBK cell cultures (0.1 µM). IFA was applied at 24, 48 and 72 h p.i.. 
Increased intensity of GFP signals indicating accumulation of host cell actin was 
found at the location of parasites of intracellular stages (Fig 27). This is an essential 
phenomenon at the early stage of PV formation (ELLIOTT and CLARK 2000). 
However, such features did not display in cultures supplemented with 500 nM 1294 at 
24 h p.i. and 48 h p.i. (Fig 28a and 28b). Accumulation of host actin was observed at 
72 h, but not typically shaped as displayed in the controls (Fig 28c). Moreover, free 
sporoziotes were found localized apart from the host cells 24 h after infection (Fig. 
29). In addition, a meront which was localized beneath the monolayer of host cells 
was firstly detected at 72 h p.i. indicating the impairing of development and 
translocation (Fig 30). 
 
 
Figure 27. bAct-GFP-MDBK cells infected with untreated C. parvum 12 h after 
infection. The white arrows point at the parasites Host cell actin was 
accumulated at the site of parasite-host cell interfaces. Scale bar length: 5 μm. 
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Figure 28. bAct-GFP-MDBK cells infected with 1294 treated C. parvum at 24 h 
(a), 48 h (b) and 72 h (c) p.i.. Anti-crypto (Dylight 647) with red fluorescent 
signal was used to specifically detect C. parvum. White arrows point at the 
parasites. Scale bar length: 5 μm. 
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Figure 29. Free C. parvm sporozoites in the culture complemented with 1294 at 
24 h p.i.. Phase contrast channel was applied along with DAPI, GFP and Dylight 
647 merged. fs: free sporozoites; as: attached sporozoites. Scale bar length: 2.5 
μm. 
 
 
Figure 30. C. parvum meront localized beneath the host cell in the culture 
supplemented with 1294 at 72 h p.i.. (a) Single layer image of meront with 
merged fluorescent channels including blue (DAPI), green (GFP) and red 
(Dylight 647). (b) 3D model constructed by Imaris (Bitplane, Zurich). White 
arrows point at the meront. Scale bar length: 2 μm.
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5. Discussion 
5.1 Sub-cloning  
As demonstrated in the current study, successful construction of recombinant plasmid 
pSC-A-5’UTR_CpCDPK1-nptII-YFP-3’UTR_CpCDPK1 which could be used to 
develop C. parvum CDPK1 knockouts was achieved. The four gene fragments were 
sequentially cloned in a mutual vector by using restriction enzymes and T4 ligase. 
This stepwise strategy mediated by specific double restriction endonucleases ensured 
the correct site and orientation of inserts. Moreover, since the chosen five enzymes 
generate sticky ends, the ligation is much more efficient than in case of blunt ends. 
The sub-cloning method was similar to the one applied by JANG et al. (2015) except 
for one step. I isolated the linearized DNA from the uncut plasmids by gel 
electrophoresis after each digestion. Self-ligation could thereby be avoided. Thus the 
risk of false positive transformation was decreased. However, an intrinsic drawback 
exists in the present strategy. During several repetitions of gel purification, the risk of 
DNA mutation may rise due to the exposure to UV light (GOODSELL 2001; 
PFEIFER et al. 2005). Therefore, the integrity of nucleotide sequence should be 
considered in further studies, and the cloning strategy may be modified to increase the 
efficiency and accuracy by using less time-consuming methods such as chain reaction 
cloning (CRC), hot fusion or One-Step Cloning (PACHUK et al. 2000; LIU et al. 
2012; FU et al. 2014).  
5.2 Inhibition of CpCDPK1 delays the host cell actin accumulation 
in vitro  
The effect of CpCDPK1 on host cell actin accumulation during the invasion process 
was elucidated. For this purpose, I established the GFP-MDBK cells. To the best of 
my current knowledge, beta actin was targeted by GFP expression in MDBK cells for 
the first time. This model provides an easy and powerful tool to study morphological 
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changes of host cells related to actin remodeling. It was proven in the current study 
that GFP could be continuously expressed for more than two weeks without any signs 
of fading. The expression remained stable through passage and cryopreservation. 
Unlike conventional studies into actin, no specific fluorescent dye is needed due to the 
expression of GFP by the transfected cells which makes the assay more reliable and 
less prone to alteration related to additional staining procedures (ELLIOTT and 
CLARK 2000).  
 
CDPK1 has been proposed as a promising drug target in apicomplexan parasites such 
as Toxoplasma gondii, Neospora caninum, Theileria equi and also, C. parvum 
(MURPHY et al. 2010; OJO et al. 2014; GIMENEZ et al. 2018). Inhibition of 
CpCDPK1 was reported to prevent both invasion and growth of C. parvum in vitro 
(CASTELLANOS-GONZALEZ et al. 2013; HUANG et al. 2017). However, 
KUHLENSCHIMDT et al. (2016) disagreed. They reported they tried to inhibit 
CpCDPK1 in vitro using various compounds. As a consequence, they found no 
correlation between the potent inhibition of CpCDPK1 and growth and cell invasion 
by C. parvum. In vivo, treatment with inhibitors appeared to be suited for control of  
cryptosporidiosis in calves (CASTELLANOS-GONZALEZ et al. 2013; LENDNER 
et al. 2015).  
 
In the present study, the CpCDPK1 inhibitor compound 1294 was found to 
profoundly depress host cell actin accumulation in vitro. As the accumulation is an 
essential and characteristic process in C. parvum invasion (ELLIOTT and CLARK 
2000; ELLIOTT et al. 2001), the invasion was also depressed. Cell invasion by C. 
parvum was fully completed in 24 h in the control group, and no free sporozoites were 
observed after this incubation period. In fact, the parasite might have finished the 
invasion much sooner, since it was reported that sporozoites may invade host cells 
within 30 s (FORNEY et al. 1999). The finding of free and invading sporozoites in 
inhibitor treated cell cultures at 24 h p.i. suggested that the invasion was rather 
delayed than completely prevented by supplementation of 1294.  
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Moreover, one meront was detected at 72 h after inoculation in the inhibitor treated 
cultures. This indicates that although the invasion and growth of C. parvum was 
impaired, development was not completely prevented. These findings are in contrast 
to the those of HUANG et al (2017).They conclude that the CDPK1 inhibitor can 
prevent the growth and proliferation of C. parvum in vitro.  
 
Interestingly, the meront I found was initially regarded to be located extracellularly.  
Because its vertical location differed from the layer that most cells and other parasites 
were at with a distance larger than 5 μm. Extracellular development of C. parvum was 
reported in previous studies, however, in axenic cultures (HIJJAWI et al. 2004; 
ALDEYARBI and KARANIS 2016). When the respective picture was further 
processed by the 3D image analysis, this meront was also found embraced by host cell 
actin. Therefore, in the present experiment host cell actin was indeed utilized by C. 
parvum to form PV which is consistent to the results of previous studies (ELLIOTT 
and CLARK 2000; ELLIOTT et al. 2001; O'HARA et al. 2004). It remains an open 
question that needed to be investigated in further studies whether the inhibition of 
CpCDPK1 leads to the observed untypical translocation of the meront? If this is the 
case, does the translocation alter the activity or virulence of C. parvum? 
 
Altogether, inhibition of host cell actin remodeling by the CpCDPK1 inhibitor 1294 
did not completely block the invasion and growth of the parasite. However, invasion 
was reduced and consequently development of further parasitic stages was impaired. 
Genotypic variation between strains may also affect drug sensitivity (WIDMER 1998). 
Drug sensitivity of Cryptosporidium spp. is related to the particular parasitic site, the 
unique structure of the PV, and the parasite’s ability to block drug influx. All of these 
features are determined by the genome (WIDMER et al. 1998; MEAD 2002). It 
appears possible that 1294 is well suited to impair invasion and development of 
particular strains such as the one used in my experiments (in house strain 
LE-08-Cp-08, GP60 subtype IIa A15G2RI) whereas other strains may react less 
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sensitive, like e.g. the Iowa strain (CASTELLANOS-GONZALEZ et al. 2013). 
Future study is needed evaluate this consideration.  
5.3 RAGgc x IFN-gamma KO mice for C. parvum propagation 
 
Although in vitro culture is applied to study C. parvum in many laboratories 
worldwide, oocyst formation is generally lacking or low in in vitro systems and thus 
propagation of C. parvum still depends on infected animals (RYAN and HIJJAWI 
2015). Laboratory mice were found to be basically susceptible to C. parvum infection, 
however, reproduction is generally insufficient in immunocompetent adult mice. 
Neonatal mice were suggested to be better suited than adults due to the undeveloped 
immune system (MCDONALD et al. 2004; FILATOVA et al. 2018), however, they 
are difficult to handle and rather unsuitable for clinical studies. Several groups 
attempted to make adult mice more susceptible to C. parvum by various strategies 
including malnutrition or pharmacological induction of immunodeficiency (COSTA 
et al. 2012; GORLA et al. 2014; MEAD et al. 1991). Genetically induced 
immunodeficiency, particularly knock out of IFN gamma (GKO), appears to be a 
promising strategy to promote acute infection and increase oocyst production in 
laboratory rodents. However, prolonged watery diarrhea may not be seen in such 
models either (GRIFFITHS et al. 1998b). In general, immunodepressed mice display 
only moderate sensitivity to cryptosporidiosis while, GKO mice appear to be a more 
sensitive model due to the low infection dose needed to induce successful infection 
and massive production of oocysts.  
 
Diarrhea as a typical symptom of cryptosporidiosis in the natural host is not observed 
in any mice model whereas other clinical signs and even mortality were recorded in 
our GKO model. The ideal laboratory infection model should fulfil the following 
demands: (1) high morbidity (2) low to moderate mortality (3) short prepatency (4) 
high oocyst yield (5) low infection dose. We evaluated crossbreds of two 
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immunodeficient parent mouse lines for fulfilment of these criteria under strictly 
controlled laboratory conditions.  
 
Interleukin-2 receptor gamma chain KO (common gamma chain (gc) deficient) mice 
lack functional receptors for various cytokines. Consequently, the numbers of 
lymphocytes are greatly reduced. 350-fold reduction of NK cells and nearly 10-fold 
reduction of B and T cells were reported (DISANTO et al. 1995). Differentiation of B 
and T lymphocytes demands so-called V (D) J recombination which includes a series 
of complex reactions. RAG1 and RAG2 collaborate in events that are essential for 
initiation of V (D) J recombination (ROTH and CRAIG 1998; CHEN et al. 1993). 
Hence, the genetically induced deficiency in RAG2 reinforces the negative effect of 
gc deletion on lymphocyte differentiation as observed in RAGgc KO mice 
(MAZURIER et al. 2004). 
   
NK cells and IFN-gamma play important roles in innate immunity against C. parvum 
as observed in experimentally infected RAG2 KO and RAGgc KO mice 
(MCDONALD et al. 2013). Severe clinical symptoms including weight loss, fur 
roughness, listlessness and mortality showed up in RAGgc KO mice. Similar patterns 
of chronic infection were seen in these two mouse strains for up to 91 days 
(BARAKAT et al. 2009). In our RAGgc x IFN-gamma KO crossbreds 
cryptosporidiosis appeared to be a more acute disease thus rather simulating the 
situation in the natural host. Mortality was seen from SD 15 onwards, and up to 6 of 
21 mice died or had to be sacrificed. This is consistent to the report of GRIFFTHS et 
al. (1998) and may reflect that various types of lymphocytes and cytokines are 
involved in host defence, IFN-gamma plays the most pivotal role. In RAGgc x 
IFN-gamma KO mice no correlation was found between the infection dose and the 
course of the disease within the chosen range of oocysts applied. We therefore 
propose that even a dose as low as 500 oocysts per mice is sufficient and appropriate 
for production of large numbers of oocysts and to induce clinical signs of disease in 
this animal model.  
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NOVAK and STERLLING (1991) reported that wildtype mice older than 26 days 
were not susceptible to infection by C. parvum. McDONALD et al. (2013) inoculated 
BALB/c mice at the age of 8 to 12 weeks with 2 × 10
7 
oocysts which resulted in an 
oocyst excretion peak 18 to 20 days after infection and full recovery in the following 
days. In our hands KO mice were very susceptible to infection even at an age of 6 
weeks. The peaks of oocysts shedding showed up much sooner and remained high for 
nearly 10 days with limited shifting until the end of the study.  
 
Positive PCR signals were recorded as early as SD1 or SD2. Since C. parvum is 
known to have a prepatent period of 4-5 days in mice, this may be explained by 
excretion of parasites that failed to infect intestinal cells or by detection of 
merozoite/meront DNA. We did not analyse this assumption, however, in the context 
of the study this aspect is not very relevant because the current studies were focused 
on the suitability of the crossbred KO model to yield high numbers of oocysts and 
observation of clinical symptoms and mortality in clinical studies. From the reported 
pattern and level of oocyst excretion and clinical observations we conclude that this 
KO animal model is very suited for laboratory scale studies and probably superior to 
previously reported mouse models. 
 
The level of oocyst shedding as calculated from qPCR data and the pattern of 
excretion were rather uniform irrespective of the infection dose in the RAGgc x 
IFN-gamma KO groups. OPG remained at a constantly high level for almost 10 days 
once peak OPG were achieved. Probably this level of continuing high level parasite 
excretion is mainly due to permanent endogenous autoinfection by thin walled 
oocysts. In immunocompetent mice (G1) OPG were likewise recorded over the whole 
study period, albeit on a much lower level, confirming the relevance of an intact 
immune system and particularly of IFN to limit intestinal replication of the parasite.  
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GRIFFITHS et al. (1998) reported a peak of oocyst excretion that was 10
2 
- 10
3 
fold 
higher in GKO mice than in immunocompetent controls. In present study, the deletion 
of both RAGgc and IFN-gamma resulted in an even higher increase of parasite 
replication by > 10
4
 fold as compared to Balb/C mice showing that combination of 
KO of at least two factors that contribute to intestinal immunity is a feasible strategy 
to optimise laboratory rodent models for cryptosporidiosis.  
 
The crossbred KO mice used in the present study were clearly more susceptible to C. 
parvum than Balb/C both in terms of parasite replication and clinical disease, however, 
diarrhoea which is a typical symptom of C. parvum infection in e.g. neonate 
ruminants, was not observed. In immunocompetent adult mice C. parvum infection is 
generally not related to clinical symptoms at all while the crossbred KO mice 
displayed clinical signs of disease such as fur roughness and increased mortality.  
 
In conclusion, this is to the best of my current knowledge the first report on RAGgc x 
IFN-gamma KO mice as a laboratory animal model for C. parvum. The model is well 
suited to propagate the parasite and to induce clinical disease accordingly. The lowest 
dose applied in this study of 500 oocysts per mouse appeared to exert the same effects 
as the tenfold dose and possibly even lower doses will result in sufficient 
multiplication of the parasite. This may be of interest not only for drug screening or 
pathogenesis research in general but particularly for scenarios where only a limited 
amount of oocysts is available for propagation, e.g. studies into field isolates or 
sub-genotypes or where research in the animal host is related to difficulties, e.g. 
studies into genetically modified C. parvum.  
 
5.4 CpCDPK1 knockout by CRISPR/cas 9 
Here, I demonstrated a method to knockout CpCDPK1 gene by using the technology 
of CRISPR/cas 9. Genomic modification of C. parvum by CRISPR/cas 9 has been 
firstly achieved by VINAYAK et al. (2015). This offered a powerful tool to overcome 
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hurdles in gene targeting or production of knockout organisms. Electroporation and 
surgical procedure were applied in their study. Different to their original protocol, I 
applied CPP for transfection and a COLO-680 N cell for propagation.  
 
Instead of conventional PCR, TD-PCR was applied to overcome problems related to 
amplification of CpCDPK1 flanked repair cassette caused by the long tailed primers. 
This method was firstly reported by DON et al. ( 1991), and then became a popular 
solution to enhance the efficacy and sensitivity of the method. Through gradually 
decreasing the annealing temperature, it is possible to abrogate false binding and 
unspecific amplification (KORBIE and MATTICK 2008). In the current experiment, 
the primers were constructed with a short complementary region plus a long 
non-complementary tail. With the Tm higher than the projected melting point, only 
very specific base pairs between primers and template. Therefore, TD PCR enhanced 
the specificity of the initial primer-template duplex formation in the first 10 cycles 
which are the most critical phase of amplification in PCR. With subsequent shifting to 
lower Tm, more permissive binding occurred yielding more of the desired  products 
(HECKER and ROUX 1996). Hence, mispriming or stochastic amplification in the 
later stage was effectively reduced due to the presence of specifically produced 
templates. 
 
Electroporation is the most commonly used method for Cryptosporidium spp. 
transfection. Due to the impulse of high voltage to introduce external DNA into cells, 
it causes a considerable ratio of sporoziote lethality (SUAREZ et al. 2017; TETENS 
et al. 2017; POTTER and HELLER 2018). Meanwhile CPPs have gained much 
attention for their ability to translocate large molecules through plasma membrane 
with low cytotoxicity (MADANI et al. 2011).  
 
Octaarginine was reported able to carry plasmid into NIH/3T3 cells (KHALIL et al. 
2004) as well as to deliver chemotherapeutic agents into Plasmodium and 
Mycobacterium (SPARR et al. 2013). In the present study, I tested its ability to 
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transport plasmid and linearized DNA into sporozoites of C. parvum. PEI was added 
to the CPP-DNA complex to increase efficiency of gene delivery into sporozoites 
(JIANG et al. 2011).  
 
Since no apparent difference in positive transfection efficiency was observed as 
compared with electroporation, it appears that octaarginine could be used as an 
alternative to electroporation, especially if no appropriate electroporation device is at 
hand. The presence of CpCDPK1 KO parasites in all subsequent passages supports 
the results found in the inhibition study. Elimination of CpCDPK1 activity impairs, 
however, does not completely block cell invasion and development.  
 
It is remarkable that the amount of external DNA necessary for transfection by CPP is 
extremely lower than that needed for electroporation. As little as 5 μg DNA was able 
to initiate the transfection whereas at least 50 μg DNA was needed for electroporation 
which is only slightly higher than the amount of 10-30 μg reported in previous papers  
(VINAYAK et al. 2015; PAWLOWIC et al. 2017) and distinctly lower than the range 
of 100-200 μg reported by others (LI et al. 2009; TETENS et al. 2017). Thus, in 
consideration of DNA consumption, transfection mediated by octaarginine is clearly 
superior to electroporation.  
 
It was proven by IFA that the transfection succeeded. In contrast, no PCR product of 
the genomic CDPK1 – repair cassette fragment was achieved in the following genetic 
assay. These might be due to the limited numbers of CDPK1 KO parasites. Because 
the nptII gene can also be expressed in the case of transient transfection caused by 
off-targets effect which is common in CRISPR/cas 9, the finding of paromomycin 
selected parasites does not guarantee successful knockout. Even though I tried to 
minimize the chance of off – target effect while designing gRNA, it appears not 
completely avoidable. Up to date, this side effect can only be controlled by the new 
technology, genome-wide CRISPR screening which needs to be carried out in further 
studies. 
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5.5 COLO-680 N cells are not suited to propagate C. parvum in 
vitro 
Irrespective of the mode of inoculation efficient propagation of C. parvum relies on 
suitable animal models. In order to avoid the negative effect of stomach passage on 
sporozoites islolated from oocysts (FAYER et al. 1991), surgical inoculation of 
transfected sporoziotes was applied by VINAYAK et al. (2015). However, 
experimental infection of animals in general and highly invasive techniques such as 
surgery is in conflict with animal welfare considerations. Unfortunately, all attempts 
to continuously culture C. parvum in cell cultures, oraganoids or under axenic 
conditions have yielded only limited or no success in terms of permanent and reliable 
delivery of oocysts (YANG et al. 2015; VARUGHESE et al. 2014; 
PAZIEWSKA-HARRIS et al. 2016). COLO-680 N cells were reported to be a 
suitable tool for sustainable in vitro generation of oocysts (MILLER et al. 2018). In 
the current study, C. parvum were observed capable of developing into various stages 
in these cells suggesting that the cell line might support infection and development. 
Besides, in most of the previous studies the growth of Cryptosporidium in vitro was 
recorded to peak at 48-72 h after infection and then to gradually decline (FAYER and 
XIAO 2008). In contrast, COLO-680 N cells were able to maintain infection as long 
as 8 weeks without further sub-infection and intensive care. This observation suggests 
COLO-680 N might be a suitable cell platform to be used not only for infection, but 
also for transfection studies as well.  
 
As shown in the results, the repair cassette was expressed from the first generation of 
the transfected C. parvum to the end of the study. However, the population of 
transfected parasites did not increase as rapid as the non-transfected ones. This might 
be attributed to the combined action of two factors, drug selection and silencing of 
CpCDPK1. The transfected parasites obtained drug resistance which supported them 
to survive the selection, however displayed reduced activities regarding cell invasion 
and further development in host cells. The relative low population of transfected 
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parasites suggests that the inhibition of CDPK1 impairs the invasion and growth of C. 
parvum on the other side. 
 
Wild type sporozoites were inoculated into at least five T25 flasks seeded with 
COLO-680 N cells when the confluency of 70 - 80% was reached, and cultivated for 
8 weeks. Supernatant of all flasks were collected every week to increase the 
probability of detection of oocysts that might have been produced in these cultures. 
Harvesting was performed exactly as described by MILLER et al. (2018). In only one 
out of four parallel experiments oocysts (6.5 × 10
4
) were detected in the present study. 
In contrast, MILLER et al. (2018) reported that in their study oocysts were observed 
every week and they calculated a 50-fold increase of oocysts at 10 days p.i. and a 
120-fold increase at 60 days p.i. (MILLER et al. 2018). Considering the initial 
inoculation dose of 4 × 10
5 
sporozoites per flask, no multiplication could be observed 
in my experiments. Therefore, a high yield of infectious oocysts appears not to be 
possible by the applied method in terms of reliability and repeatability. At least for the 
in-house strain used in the present investigation (GP60 subtype IIa A15G2RI of C. 
parvum) in vitro reproduction of the whole life cycle in COLO-680 N cells was not 
achieved on a satisfactory level.  
 
It cannot be excluded that differences between strains of C. parvum could be a factor 
that influences the success of in vitro production of oocysts. A C. parvum cattle 
genotype (Swiss cattle C26) was reported to complete its life cycle and yield 
infectious oocysts in both HCT-8 cell and axenic cultures (HIJJAWI et al. 2001; 
HIJJAWI et al. 2004). However, the method was rated not appliable to C. 
parvum Moredun or IOWA strains or the C. hominis strain TU502 (GIROUARD et al. 
2006). Unfortunately, transfected oocysts were not found in the current in vitro 
experiments. To the best of my current knowledge no continuous axenic production of 
oocysts has been established anywhere, however, would be ideal to fulfill the 3R 
principle or for studies with genetically modified C. parvum. In the foreseen near 
future, the propagation of genetically modified C. parvum still has to rely on animal 
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models. Whatsoever, efforts need to be paid on developing less harmful method than 
surgical inoculation of C. parvum into mice. 
 
The present study demonstrates the knockout of CDPK1 gene in C. parvum through 
CRISPR/cas 9 for the first time and the trials of propagate C. parvum both in vitro and 
in vivo. The animal model RAGgc x IFN-gamma KO mice is suited to serve the aim 
of propagation whereas the in vitro model, COLO - 680 N cell appears unsuited. The 
CpCDPK1 is proven very important but not absolutely essential to the invasion 
process in vitro, thus influence development into further phase of C. parvum by the 
CDPK1 inhibition assay. Due to the gene’s importance in the life cycle, a low 
percentage of transfected C. parvum survived the in vitro transfection. Therefore, 
strategies to stabilize the generation of CDPK1KO C. parvum solutions remain to be 
developed to increase the rate of survivors in further studies. One option is RAGgc x 
IFN-gamma KO mice that might allow the propagation of CDPK1KO C. parvum as 
this model only requires low number of parasites to produce high yields of oocysts. 
The other possibility is to search a new transfection method which can overcome 
barrier of occyst wall, thereby the transfected sporozoites can be well protected until 
the invasion process initiates. For the currently available transfection protocols the 
rigidity of oocyst walls are a relevant obstacle. Methods that allow large molecules to 
penetrate the oocyst wall without altering sporozoites vitality would be most welcome, 
however, are not available so far.
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6. Summary 
Wanpeng Zheng 
Calcium dependent protein kinase 1 in Cryptosporidium parvum (CpCDPK1): 
attempts to produce knockout parasites and functional studies  
Institute of Parasitology, Faculty of Veterinary Medicine, Leipzig University 
Submitted in September 2019 
88 pages, 30 figures, 16 tables, 213 references 
Keywords: Cryptosporidium parvum, CDPK1, host cell actin, transfection, 
propagation 
Introduction: Cryptosporidium parvum is a protozoan parasite that causes 
diarrhoea in many host species worldwide. CpCDPK1 appears to be essential for 
invasion and a promising drug target. 
Aim of the study: The aims of this study were to expand the knowledge of 
CpCDPK1. To achieve that, attempts were made to inhibit this gene by BKI-1294 
in vitro and generate CpCDPK1 KO C. parvum. To maintain the genetically 
modified parasites, I studied the suitability of infection and propagation in a new 
animal model RAGgc × IFN-gamma mouse and in vitro model COLO - 680 N 
cell line.  
Animals, materials and methods: 4×10
6 
freshly excysted C. parvum sporozoites 
were seeded into transfected GFP-MDBK cultures at the confluency of 70 – 80 % 
and simultaneously exposed to 500 nM of BKI-1294. IFA was applied to observe 
the invasion and host cell actin accumulation. Guide RNA (gRNA) for 
CRISPR-mediated transfection was designed and the Nluc-neoR repair cassette 
was flanked with 50 bp long 5’- and 3’UTR of CpCDPK1 by PCR. Transfection 
was performed by octaarginine transportation and compared to electroporation. 
COLO - 680 N cells with the confluency of 70 – 80% were infected with 4×106 
non-transfected and transfected sporozoites of C. parvum. To establish a 
laboratory animal model for propagation of C. parvum and drug screening 
RAGgc × IFN-gamma mice were infected with 500 (G2), 1000 (G3) and 5000 
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(G4) of oocysts. BALB/c WT mice were inoculated with 5000 (G1) oocysts as 
control. Faeces were sampled for C. parvum DNA extraction. Real time PCR was 
applied to calculate the oocyst yield. 
Results: In the presence of 500 nM BKI-1294, parasite-induced host cell actin 
accumulation was not observed at 24 and 48 h after inoculation in vitro pointing 
at altered infectivity of CDPK inhibited sporozoites. Extracellular noninvasive 
sporozoites were found at 24 h p.i., only one meront was observed in a host cell at 
72 h p.i. CRISPR-mediated gene editing was applied to C. parvum to knock out 
CDPK1. Transfected C. parvum were found in COLO-680 N cells through 6 
passages. However, no newly generated oocysts were harvested. RAGgc × 
IFN-gamma mice were tested suitable as an animal model for C. parvum 
infection studies and oocyst propagation. These crossbred mice are very sensitive 
to infection at doses as low as 500 oocysts. They displayed emaciation, rough fur 
and trembling. The survival percentage was 71.4 % (G2), 85.7 % (G3), 57.1 % 
(G4) and 100 % (G1) at the end of study. Oocyst yield of 10
8
 OPG was calculated 
in the crossbred mice whereas only 10
4 
OPG were counted in Balb/C mice. Yields 
did not differ significantly (P > 0.05) in crossbred mice infected with different 
oocysts doses.  
Conclusions: 1.The function of CpCDPK1 is obviously important to the invasion 
process including attachment and utilization of host cell actin to form PV. This 
assumption was confirmed by CDPK inhibition and genetic KO. However, 
methods that increase the transfection efficiency are needed to enhance the 
generation of KO C. parvum. 2. The transfection method mediated by 
octargninine is superior to electroporation in consideration of DNA consumption 
and requirement of device. 3. Due to the low required infection dose and clinical 
manifestation RAGgc × IFN-gamma mice appear very well suited to serve as an 
in vivo laboratory model of C. parvum infection and for propagation of 
particularly transgenic C. parvum strains. 4. COLO – 680 N cells appear suited to 
be an in vitro model for C. parvum infection and transfection study, however, not 
qualified for propagation.
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7. Zusammenfassung 
Wanpeng Zheng 
Knockout Calciumabhängiger Proteinkinase 1 (CpCDPK1) in Cryptosporidium 
parvum und Funktionsstudien 
Institut für Parasitologie, Veterinärmedizinische Fakultät, Universität Leipzig 
Eingereicht im September 2019 
88 Seiten, 30 Abbildungen, 16 Tabellen, 213 Literaturangaben 
Schlüsselwörter: Cryptosporidium parvum, CpCDPK1, Wirtszellaktin, Transfektion, 
Mausmodell 
Einleitung: Cryptosporidium parvum ist ein parasitärer Protozoe, der bei vielen Wirtsarten 
Durchfall verursacht. CpCDPK1 scheint für die Invasion essentiell und ein 
vielversprechendes therapeutisches Ziel zu sein. 
Ziele der Untersuchungen: Der CDPK-Inhibitor BKI-1294 wurde auf seine Wirkung auf 
C. parvum in vitro untersucht. Ferner sollte versucht werden eine Knock-out-Mutante des 
CDPK1 kodierenden Gens (CpCDPK1KO) herzustellen. Ein Mausmodell sowie eine 
Zelllinie wurden auf ihre Eignung zur Oozystenproduktion getestet. 
Tiere, Material und Methoden: 4 × 10
6 
frisch exzystierte C. parvum-Sporozoiten wurden 
in MDBK-Kulturen ausgesät und gleichzeitig 500 nM des CDPK-Inhibitors BKI-1294 
ausgesetzt. Mittels IFA wurden die Invasion und die Akkumulation von Wirtszell-Aktin 
dargestellt. GuideRNA (gRNA) wurde für die CRISPR-vermittelte Transfektion entworfen 
und in das Plasmid 185 integriert. Die Nluc-neoR-Reparaturkassette wurde mit 50 bp 
langen 5'- und 3'-UTRs des CpCDPK1-Gens flankiert. Die Transfektion wurde mittels 
Octaarginin durchgeführt und mit der Elektroporation verglichen. Konfluente COLO - 680 
N-Zellen wurden mit 4 × 10
6 
transfizierten und nicht transfizierten Sporozoiten infiziert 
und für 8 Wochen kultiviert und anschließend auf Oozystenproduktion untersucht. 7 
Immundefiziente RAGgc × IFN-Gamma-Mäuse wurden mit 500 (G2), 1000 (G3) oder 
5000 (G4) Oozysten infiziert. 6 BALB/c WT-Mäuse wurden mit 5000 (G1) Oocysten als 
Kontrolle inokuliert. Mittels PCR wurde die Oozystenausbeute bestimmt. 
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Ergebnisse:In Gegenwart von 500 nM BKI-1294 wurde 24 und 48 h post infectionem (p.i.) 
in vitro keine Aktinakkumulation in Wirtszellen beobachtet, was auf eine reduzierte 
Infektiosität von CDPK-inhibierten Sporozoiten hinweist. Extrazelluläre nicht-invasive 
Sporozoiten wurden 24 h p.i. gefunden, 72 h p.i. wurde ein Meront festgestellt. 
CRISPR-vermittelte Geneditierung wurde angewendet, um CpCDPK1 mittels guideRNA 
auszuschalten. Mittels Octaarginin wurden die jeweilige gRNA und die amplifizierte 
Reparaturkassette in die Zielzelle transportiert. So transfizierte C. parvum wurden in 
COLO-680 N-Zellen über 6 Wirtszellpassagen gefunden. Es wurden jedoch keine neu 
erzeugten Oozysten gefunden. RAGgc × IFN-Gamma-Mäuse erwiesen sich schon bei 
Dosen von nur 500 Oozysten als sehr anfällig für C. parvum. Mäuse zeigten Abmagerung, 
raues Fell und Zittern, die Überlebensrate betrug am Ende der Studie 71,4% (G2), 85,7% 
(G3), 57,1% (G4), BalbC-Mäuse überlebten dagegen zu 100% (G1). Eine 
Oozystenausbeute von bis zu 10
8
 OPG wurde für die Gruppen G2, G3 und G4 berechnet 
(P > 0,05), wohingegen Balb/C-Mäuse nur 10
4
 OPG ausschieden. 
Schlussfolgerungen: 1. CpCDPK1 ist wichtig für den Invasionsprozess, einschließlich der 
Mobilisierung von Wirtszell-Aktin zur Bildung der parasitophoren Vakuole. Dies konnte 
durch Anwendung des Inhibitors BKI-1294 und Knock-out-Studien gezeigt werden. Es 
werden jedoch Verfahren benötigt, die die Transfektionseffizienz erhöhen. 2. Die durch 
Octaarginin vermittelte Transfektion ist der Elektroporation überlegen. 3. RAGgc × 
IFN-Gamma-Mäuse sind sehr gut als Labornagermodell geeignet. 4. COLO - 680 N - 
Zellen scheinen als In-vitro-Modell für Infektions- und Transfektionsstudien geeignet zu 
sein, ermöglichen jedoch nicht eine Vermehrung des Parasiten. 
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